Share on Facebook Share on Twitter Email
Answers.com

virus

 
Dictionary: vi·rus   ('rəs) pronunciation
n., pl., -rus·es.
    1. Any of various simple submicroscopic parasites of plants, animals, and bacteria that often cause disease and that consist essentially of a core of RNA or DNA surrounded by a protein coat. Unable to replicate without a host cell, viruses are typically not considered living organisms.
    2. A disease caused by a virus.
  1. Something that poisons one's soul or mind: the pernicious virus of racism.
  2. Computer Science. A computer virus.

[Latin vīrus, poison.]


Search unanswered questions...
Enter a question here...
Search: All sources Community Q&A Reference topics

The influenza virus possesses both a protein shell (capsid) and a lipid and protein envelope. The …
(click to enlarge)
The influenza virus possesses both a protein shell (capsid) and a lipid and protein envelope. The … (credit: © Merriam-Webster Inc.)
Microscopic, simple infectious agent that can multiply only in living cells of animals, plants, or bacteria. Viruses are much smaller than bacteria and consist of a single- or double-stranded nucleic acid (DNA or RNA) surrounded by a protein shell called a capsid; some viruses also have an outer envelope composed of lipids and proteins. They vary in shape. The two main classes are RNA viruses (see retrovirus) and DNA viruses. Outside of a living cell, a virus is an inactive particle, but within an appropriate host cell it becomes active, capable of taking over the cell's metabolic machinery for the production of new virus particles (virions). Some animal viruses produce latent infections, in which the virus persists in a quiet state, becoming periodically active in acute episodes, as in the case of the herpes simplex virus. An animal can respond to a viral infection in various ways, including fever, secretion of interferon, and attack by the immune system. Many human diseases, including influenza, the common cold, and AIDS, as well as many economically important plant and animal diseases, are caused by viruses. Successful vaccines have been developed to combat such viral diseases as measles, mumps, poliomyelitis, smallpox, and rubella. Drug therapy is generally not useful in controlling established viral infections, since drugs that inhibit viral development also inhibit the functions of the host cell. See also adenovirus; arbovirus; bacteriophage; picornavirus; plant virus; poxvirus.

For more information on virus, visit Britannica.com.

Any of a heterogeneous class of agents that share three characteristics: (1) They consist of a nucleic acid genome surrounded by a protective protein shell, which may itself be enclosed within an envelope that includes a membrane; (2) they multiply only inside living cells, and are absolutely dependent on the host cells' synthetic and energy-yielding apparatus; (3) the initial step in multiplication is the physical separation of the viral genome from its protective shell, a process known as uncoating, which differentiates viruses from all other obligatorily intracellular parasites. In essence, viruses are nucleic acid molecules, that is, genomes that can enter cells, replicate in them, and encode proteins capable of forming protective shells around them. Terms such as “organism” and “living” are not applicable to viruses. It is preferable to refer to them as functionally active or inactive rather than living or dead.

Electron micrographs of highly purified preparations of some viruses. (<i>a</i>) Adenovirus. (<i>b</i>) Rotavirus. (<i>c</i>) Influenza virus (<i>courtesy of George Leser</i>). (<i>d</i>) Vesicular stomatitis virus. (<i>e</i>) Tobacco mosaic virus. (<i>f</i>) <ailnk tname=Alfalfa mosaic virus. (g) T4 bacteriophage. (h) M13 bacteriophage.">
Electron micrographs of highly purified preparations of some viruses. (a) Adenovirus. (b) Rotavirus. (c) Influenza virus (courtesy of George Leser). (d) Vesicular stomatitis virus. (e) Tobacco mosaic virus. (f) Alfalfa mosaic virus. (g) T4 bacteriophage. (h) M13 bacteriophage.

The primary significance of viruses lies in two areas. First, viruses destroy or modify the cells in which they multiply; they are potential pathogens capable of causing disease. Many of the most important diseases that afflict humankind, including rabies, smallpox, poliomyelitis, hepatitis, influenza, the common cold, measles, mumps, chickenpox, herpes, rubella, hemorrhagic fevers, and the acquired immunodeficiency syndrome (AIDS) are caused by viruses. Viruses also cause diseases in livestock and plants that are of great economic importance. See also Acquired immune deficiency syndrome (AIDS); Plant pathology.

Second, viruses provide the simplest model systems for many basic problems in biology. Their genomes are often no more than one-millionth the size of, for example, the human genome; yet the principles that govern the behavior of viral genes are the same as those that control the behavior of human genes. Viruses thus afford unrivaled opportunities for studying mechanisms that control the replication and expression of genetic material. See also Human Genome Project.

Although viruses differ widely in shape and size (see illustration), they are constructed according to certain common principles. Basically, viruses consist of nucleic acid and protein. The nucleic acid is the genome which contains the information necessary for virus multiplication and survival, the protein is arranged around the genome in the form of a layer or shell that is termed the capsid, and the structure consisting of shell plus nucleic acid is the nucleocapsid. Some viruses are naked nucleocapsids. In others, the nucleocapsid is surrounded by a lipid bilayer to the outside of which “spikes” composed of glycoproteins are attached; this is termed the envelope. The complete virus particle is known as the virion, a term that denotes both intactness of structure and the property of infectiousness.

Viral genomes are astonishingly diverse. Some are DNA, others RNA; some are double-stranded, others single-stranded; some are linear, others circular; some have plus polarity, other minus (or negative) polarity; some consist of one molecule, others of several (up to 12). They range from 3000 to 280,000 base pairs if double-stranded, and from 5000 to 27,000 nucleotides if single-stranded. See also Virus classification.

Viral genomes encode three types of genetic information. First, they encode the structural proteins of virus particles. Second, most viruses encode enzymes capable of transcribing their genomes into messenger RNA molecules that are then translated by host-cell ribosomes, as well as nucleic acid polymerases capable of replicating their genomes; many viruses also encode nonstructural proteins with catalytic and other functions necessary for virus particle maturation and morphogenesis. Third, many viruses encode proteins that interact with components of host-cell defense mechanisms against invading infectious agents. The more successful these proteins are in neutralizing these defenses, the more virulent viruses are.

The two most commonly observed virus-cell interactions are the lytic interaction, which results in virus multiplication and lysis of the host cell; and the transforming interaction, which results in the integration of the viral genome into the host genome and the permanent transformation or alteration of the host cell with respect to morphology, growth habit, and the manner in which it interacts with other cells. Transformed animal and plant cells are also capable of multiplying; they often grow into tumors, and the viruses that cause such transformation are known as tumor viruses. See also Cancer (medicine); Oncology; Retrovirus; Tumor viruses.

There is little that can be done to interfere with the growth of viruses, since they multiply within cells, using the cells' synthetic capabilities. The process, interruption of which has met with the most success in preventing virus multiplication, is the replication of viral genomes, which is almost always carried out by virus-encoded enzymes that do not exist in uninfected cells and are therefore excellent targets for antiviral chemotherapy. Another viral function that has been targeted is the cleavage of polyproteins, precursors of structural proteins, to their functional components by virus-encoded proteases; this strategy is being used with some success in AIDS patients. See also Chemotherapy; Cytomegalovirus infection; Herpes; Influenza; Respiratory syncytial virus.

Antiviral agents on which much interest is focused are the interferons. Interferons are cytokines or lymphokines that regulate cellular genes concerned with cell division and the functioning of the immune system. Their formation is strongly induced by virus infection; they provide the first line of defense against viral infections until antibodies begin to form. Interferons interfere with the multiplication of viruses by preventing the translation of early viral messenger RNAs. As a result, viral capsid proteins cannot be formed and no viral progeny results.

By far the most effective means of preventing viral diseases is by means of vaccines. There are two types of antiviral vaccines, inactivated virus vaccines and attenuated active virus vaccines. Most of the antiviral vaccines currently in use are of the latter kind. The principle of antiviral vaccines is that inactivated virulent or active attenuated virus particles cause the formation of antibodies that neutralize a virulent virus when it invades the body. See also Animal virus; Plant viruses and viroids; Vaccination; Virus, defective.


Software used to infect a computer. After the virus code is written, it is buried within an existing program. Once that program is executed, the virus code is activated and attaches copies of itself to other programs in the system. Infected programs copy the virus to other programs.

The effect of the virus may be a simple prank that pops up a message on screen out of the blue, or it may destroy programs and data right away or on a certain date. It can lay dormant and do its damage once a year. For example, the Michelangelo virus contaminates the machine on Michelangelo's birthday.

Viruses Must Be Run to Do Damage

A virus is not inserted into data. It is a self-contained program or code that attaches itself to an existing application in a manner that causes it to be executed when the application is run. Macro viruses, although hidden within documents (data), are similar. It is in the execution of the macro that the damage is done.

E-Mail Attachments Are Suspect

Files attached to e-mail messages are a common way of infecting a computer when the recipient is not aware of file types that are potentially harmful. For example, files with extensions such as .EXE, .BAT and .COM can perform any operation within the computer and should never be clicked unless the user is expecting the attachment. See dangerous extensions and double extension.

Viruses Are Relatively Recent

The term virus was coined in the early 1980s, supposedly after a graduate student presented the concept of a program that could "infect" other programs. Since then, more than 80,000 viruses have been defined. However, 99% of the infections are from only a few hundred variants found "in the wild."

Since 1993, the WildList Organization has been keeping track of virus attacks around the world. For more information, visit www.wildlist.org. For a sampling of different virus infections, see virus examples. See in the wild, quarantine, disinfect, macro virus, e-mail virus, behavior blocking, polymorphic virus, stealth virus, worm, boot virus, vandal, virus hoaxes and crypto rage.

Be Careful Out There!

If you use the Internet for any purpose, be sure you have an antivirus program running at all times (see antivirus program).

Download Computer Desktop Encyclopedia to your iPhone/iTouch

World of the Body: virus
Top

From the Latin for toxin. These are very tiny microorganisms not visible with an ordinary microscope but only through electron microscopy. They have a very simple structure, and often consist only of DNA or RNA with a protein coat. They therefore lack some of the chemicals and enzymes needed for replication, so instead they infect other living cells and take over the infected cell's internal ‘machinery’.

— Angharad Puw Davies

See microorganisms.

Thesaurus: virus
Top

noun

    Anything that is injurious, destructive, or fatal: bane, canker, contagion, poison, toxin, venom. See help/harm/harmless.

Dental Dictionary: virus
Top
(vī' rus)
n

One of a group of heterogeneous infective agents characterized by the lack of independent metabolism or the ability to replicate outside the host cell.

A virus is a parasite that must infect a living cell to reproduce. Although viruses share several features with living organisms, such as the presence of genetic material (DNA or RNA), they are not considered to be alive. Unlike cells, which contain all the structures needed for growth and reproduction, viruses are composed of only an outer coat (capsid), the genome, and, in some cases, a few enzymes. Together these make up the virion, or virus particle. Many illnesses in humans, including AIDS, influenza, Ebola fever, the common cold, and certain cancers, are caused by viruses. Viruses also exist that infect animals, plants, bacteria, and fungi.

Physical Description and Classification

Viruses are distinguished from free-living microbes, such as bacteria and fungi, by their small size and relatively simple structures. Diminutive viruses such as parvovirus may have a diameter of only 25 nanometers (nm, 10-9 meters). Poxviruses, the largest known viruses, are about 300 nanometers across, just at the detection limits of the light microscope. Typical bacteria have diameters of 1,000 nanometers or more. Information on the structure of viruses has been obtained with several techniques, including electron microscopy (EM). The limit of resolution of traditional EM is about 5 nm. With advanced EM techniques, such as cryogenic EM (cryoEM, in which the sample is rapidly frozen instead of exposed to chemical fixatives), coupled with computer image processing, smaller structures (1-2 nm) can be resolved. However, X-ray crystallography is the only method that allows for atomic-level resolution. Small viruses that produce uniform particles can be crystallized. The first atomic-level structure of a virus, tomato bushy stunt virus, was solved in 1978.

Table 1

Nucleic AcidPolarityFamilyExamplesHostDiseases/pathologies
ss DNA+Parvoviridaeparvovirus B19humanserythema infectiosum (fifth disease)
ds DNA+/-MyoviridaeBacteriophage T4E. colibacterial lysis
PapillomaviridaeHPV types 2, 16, 18, 33humanswarts, cervical and other cancers
Herpesviridaeherpes zoster virushumanschicken pox, shingles
Poxviridaevariola virushumanssmallpox
ss RNA non-seg.+Picornaviridaepoliovirus types 1-3humanspoliomyelitis
rhinovirus (100+ serotypes)humanscommon cold
Togaviridaeequine encephalitis virusinsects/horsesCNS disease in horse and humans
ss RNA non-seg.-Rhabdoviridaerabies virusmammalsrabies
Paramyxoviridaemeasles virushumansmeasles
ssRNAt segmented-Orthomyxovirusesinfluenza virusmammals, birdsinfluenza
ssRNA segmented-and/or ambiBunyaviridaeSin Nombre virusrodentshanta fever
ArenaviridaeLassa fever virusprimateshemorrhagic fever
ds RNA+/-ReoviridaeRice dwarf virusplantsstunting
ssRNA DNA rep. int.+RetroviridaeHIV types 1, 2humansAIDS
HTLV type Ihumansadult T-cell leukemia
ds DNA +/-RNA rep. int.+/-Hepadnaviridaehepatitis B virushumanshepatitis, hepatocellular carcinoma
ss=single-stranded;ds=doublestranded; non-seg.=non-segmented; ambi = ambisense;rep. int = replicativeintermediate; HPV= human papillomavirus;CNS = centralnervous system.

There is great diversity among viruses, but a limited number of basic designs. Capsids are structures that contain the viral genomes; many have icosahedral symmetry. An icosahedron is a three-dimensional, closed shape composed of twenty equilateral triangles. Viral proteins, in complexes termed "capsomers," form the surface of the icosahedron.

Other viruses, such as the virus that causes rabies, are helical (rod shaped). The length of helical viruses can depend on the length of the genome, the DNA or RNA within, since there are often regular structural interactions between the nucleic acids of the genome and the proteins that cover it.

A lipid-containing envelope is a common feature of animal viruses, but uncommon in plant viruses. Embedded in the envelope are surface proteins, usually glycoproteins that help the virus interact with the surface of the cell it is infecting. A matrix layer of proteins often forms a bridge between the surface glycoproteins and the capsid. Some viruses, such as the picornaviruses, are not enveloped, nor do they have a matrix layer. In these viruses, cell-surface interactions are mediated by the capsid proteins.

Some viruses have compound structures. The head of the T4 bacterial virus (bacteriophage) is icosahedral and is attached via a collar to a contractile tail with helical symmetry. Large viruses, such as the herpesviruses and poxviruses, can have higher-ordered and more complex structures.

Table 2

MoleculeSequencePolarity or Sense
Complementary RNAA U U G G G C U Cnegative
Coding strand DNAT A A C C C G A Gpositive
Complementary DNAA T T G G G C T Cnegative
mRNAU A A C C C G A Gpositive

Classification of viruses considers the genome characteristics, virion shape and macromolecular composition, and other properties, such as antigenicity and host range. A scheme for classification of viruses based on the type of nucleic acid (DNA or RNA) present in the virus particle and the method of genome replication was devised by David Baltimore, co-discoverer of reverse transcriptase (see Table 1). Reverse transcriptase is an enzyme that converts retroviral genomic single-stranded (ss) RNA into doubled-stranded (ds) DNA.

Viral genomes can be RNA or DNA, positive or negative in polarity, ss or ds, and one continuous (sometimes circular) molecule or divided into segments. By convention, messenger RNA (mRNA) that can be directly translated to protein is considered positive sense (or positive in polarity). DNA with a corresponding sequence (that is, the coding strand of double-stranded DNA) is also a positive-sense strand. An RNA or DNA molecule with the reverse complementary sequence to mRNA is a negative-sense strand. A few viruses have been identified that contain one or more "ambisense" genomic RNA segments that are positive sense in one part of the molecule (this part can be translated directly into protein) and negative sense (reverse complement of coding sequence) in the rest of the molecule.

Virus Replication Cycle

For a virus to multiply it must infect a living cell. All viruses employ a common set of steps in their replication cycle. These steps are: attachment, penetration, uncoating, replication, assembly, maturation, and release.

Attachment and Penetration

A virion surface protein must bind to one or more components of the cell surface, the viral receptors. The presence or absence of receptors generally determines the type of cell in which a virus is able to replicate. This is called viral tropism. For example, the poliovirus receptor is present only on cells of higher primates and then in a limited subset of these, such as intestine and brain cells. While called virus receptors, these are actually used by the cell for its own purposes, but are exploited by the virus for entry.

Entry of the viral genome into the cell can occur by direct penetration of the virion at the cell surface or by a process called endocytosis, which is the engulfment of the particle into a membrane-based vesicle. If the latter, the virus is released when the vesicle is acidified inside the cell. Enveloped viruses may also fuse with the cellular surface membrane, which results in release of the capsid into the cytoplasm. Surface proteins of several viruses contain "fusion peptides," which are capable of interacting with the lipid bilayers of the host cell.

Uncoating and Replication

After penetration, viral capsid proteins must be removed, at least partly, to express and replicate the viral genome. In the case of most DNA viruses, the capsid is routed to the nucleus prior to uncoating. An example can be seen in the poxviruses, whose large DNA genomes encode most of the proteins needed for DNA replication. These viruses uncoat and replicate completely in the cytoplasm. RNA viruses typically lose the protective envelope and capsid proteins upon penetration into the cytoplasm. In reoviruses, only an outer protein shell is removed and replication takes place inside a structured subviral particle.

Viral genomes must be expressed as mRNAs in order to be translated into structural proteins for the capsids and, in some cases, as replicative proteins for replicating the virus genome. Viral genomes must also provide templates that can be replicated to produce progeny genomes that will be packaged into newly produced virions. Replication details vary among the different types of viruses.

The ss positive-sense DNA of parvoviruses is copied by host DNA polymerase (the enzyme that replicates DNA) in the nucleus into a negative-sense DNA strand. This in turn serves as a template for mRNA and progeny DNA synthesis. The genomes of larger DNA viruses, with the exception of the poxviruses, are also transcribed and replicated in the nucleus by a combination of viral and host enzymes (for example, DNA-dependent RNA polymerses for transcription of mRNAs, DNA-dependent DNA polymerase for genome replication).

Positive-polarity RNA virus genomes can be translated directly, but for effective progeny production additional rounds of RNA replication via a negative-stranded intermediate are required. This is accomplished by a viral transcriptase (RNA-dependent RNA polymerase) and associated cofactors. Single-stranded negative-sense RNA viruses of animals must also carry a viral transcriptase to transcribe functional mRNAs and subsequently produce proteins, since this RNA-to-RNA enzymatic activity is typically lacking in animal cells.

Retroviruses are unique among viruses in that the genome is diploid, meaning that two copies of the positive-polarity RNA genome are in each virus particle. The genomic RNA is not translated into protein, but rather serves as a template for reverse transcription, which produces a double-stranded DNA via a viral reverse transcription enzyme. The DNA is subsequently integrated into the host cell chromosomal DNA. Hepadnaviruses also encode a reverse transcriptase, but replication occurs inside the virus particle producing the particle-associated genomic DNA.

Assembly, Maturation, and Release

As viral proteins and nucleic acids accumulate in the cell, they begin a process of self-assembly. Viral self-assembly was first demonstrated in a seminal series of experiments in 1955, wherein infectious particles of tobacco mosaic virus spontaneously formed when purified coat protein and genomic RNA were mixed. Likewise, poliovirus capsomers are known to self-assemble to form a procapsid in the cytoplasm. Progeny positive-strand poliovirus RNAs then enter this nascent particle. "Chaperone" proteins (chaparonins) of the cell play a critical role in facilitating the assembly of some viruses. Their normal role is to help fold cellular proteins after synthesis.

The maturation and release stages of the replication cycle may occur simultaneously with the previous step, or may follow in either order. Many viruses assemble their various components into "immature" particles. Further intracellular or extracellular processing is required to produce a mature infectious particle. This may involve cleavage of precursors to the structural proteins, as in the case of retroviruses.

Viruses that are not enveloped usually depend upon disintegration or lysis of the cell for release. Enveloped viruses can be released from the cell by the process of budding. In this process the viral capsid and usually a matrix layer are directed to a modified patch of cellular membrane. Interactions between the matrix proteins and/or envelope proteins drive envelopment. In the case of viruses that bud at the cell surface, such as some togaviruses and retroviruses (including HIV), this also results in release of the virus particles. If the virus acquires a patch of the nuclear membrane (as is the case with herpesviruses), then additional steps involving vesicular transport may be required for the virus to exit the cell.

Infection Outcomes

Viral infection can result in several different outcomes for the virus and the cell. Productive infection, such that each of the seven steps outlined above occurs, results in the formation of progeny viruses. Cells productively infected with poliovirus can yield up to 100,000 progeny virions per cell, although only a small fraction (fewer than 1 per 1,000) of these are capable of going on to carry out a complete replication cycle of their own. Productive infection may induce cell lysis, which results in the death of the cell. Nonenveloped viruses typically induce cell lysis to permit release of progeny virions. Many enveloped viruses also initiate events that result in cell death by various means, including apoptosis, necrosis, or lysis.

Viral infection may be abortive, in which one or more necessary factors, either viral or cellular, are absent and progeny virions are not made. Infection may be nonproductive, at least transiently, but viral genomes may still become resident in the host cell. Herpesviruses and retroviruses can establish latent infections. Latently infected cells may express a limited number of viral products, including those that result in cell transformation. Latent infections can often be activated by various stimuli, such as stress in the case of herpesviruses, to undergo a productive infection.

Viral Cancers

Infection with certain viruses can also result in cell transformation, stable genetic changes in the cell that result in disregulated cell growth and extended growth potential (immortalization). In animals, such virally induced cellular changes can result in cancer. This correlation was first made by Harry Rubin and Howard Temin in the 1950s, when they observed that Rous sarcoma virus, a retrovirus capable of inducing solid tumors in chickens, could also cause biochemical and structural changes and extend the proliferative potential of cultured chicken cells.

Viruses are perhaps second only to tobacco as risk factors for human cancers. DNA tumor viruses include papillomaviruses and various herpes viruses (such as HHV-8, which causes Kaposi's sarcoma). More than sixty strains of human papillomaviruses (HPV) have been identified. HPV cause warts, which are benign tumors, but are also the causes of malignant penile, vulval, and cervical cancers. Infection with hepatitis B or C viruses is associated with increased incidence of liver cancer. Adenoviruses have been shown to induce cancers in animals, but not in humans. Retroviruses can also cause cancer in various animal species, including humans. HTLV-1 causes adult T-cell leukemia in about 1 percent of infected humans.

Viruses can cause cancer through their effects on two important cellular genes or gene products: tumor suppressors and oncogenes. These genes are critical players in cell-cycle regulation. One protein product from HPV binds to the retinoblastoma (Rb) tumor suppressor protein. HPV E6 protein binds p53 tumor suppressor protein and promotes its degradation. Acutely transforming retroviruses, which induce tumors in a short time period of weeks to months, carry modified versions of cellular oncogenes, called viral oncogenes. Slowly transforming retroviruses also subvert cellular oncogenes, but by integrating into or near the oncogene, thereby altering its expression, a process that can take years because of the apparently random nature of retrovirus integration.

Vaccines

Many viral infections can be prevented by vaccination. Several classes of vaccines are currently in use in humans and animals. Inactivated vaccines, such as the poliovirus vaccine developed by Jonas Salk, are produced from virulent viruses that are subjected to chemical treatments that result in loss of infectivity without complete loss of antigenicity (antigenicity is the ability to produce immunity). Another approach is the use of weakened variants of a virus with reduced pathogenicity to induce a protective immune response without disease. While vaccines are usually given before exposure to a virus, postexposure vaccines can cure some virus infections with extended incubation periods, such as rabies.

Vaccines against smallpox eradicated the illness in 1980. It is believed that it may also be possible to eliminate polio. A recombinant vaccine against hepatitis B virus is now produced in yeast. However, developing effective vaccines to some viruses, including the common cold viruses, HIV-1, herpesviruses, and HPV, is proving very difficult principally due to the existence of many variants. Public health measures, such as mosquito control programs to curb the spread of viral diseases transmitted by these vectors, and safe-sex campaigns to slow the spread of sexually transmitted diseases, can also be effective. Because viruses replicate in cells, drugs that target viruses typically also affect cell functions. These therapeutic agents must be active against the virus while having "acceptable toxicity" to the host organism. The majority of the specific antiviral drugs currently in use target viral enzymes. For example, nucleoside analogues that target viral polymerases are active against HIV and certain herpesviruses.

Bibliography

Garrett, Laurie. The Coming Plague: Newly Emerging Diseases in a World out of Balance. New York: Penguin Books, 1994.

Kolata, Gina B. Flu: The Story of the Great Influenza Pandemic of 1918 and the Search for the Virus That Caused It. New York: Farrar, Straus and Giroux, 1999.

Preston, Richard. The Hot Zone. New York: Random House, 1994.

Internet Resource

Sanders, David M., and Robert F. Garry. "All the Virology on the World Wide Web." www.virology.net.

—Robert F. Garry

A member of a group of minute infectious agents that have a relatively simple structure and can reproduce only within living cells. Viruses consist of genetic material (either DNA or RNA) surrounded by a protein coat. They are responsible for many diseases including the common cold, influenza, and AIDS. They are not affected by antibiotics, but many viral diseases can be effectively treated by vaccines.

 
virus, parasite with a noncellular structure composed mainly of nucleic acid within a protein coat. Viruses usually are too small (100-2,000 Angstrom units) to be seen with the light microscope and thus must be studied by electron microscopes. In one stage of their life cycle, in which they are free and infectious, virus particles do not carry out the functions of living cells, such as respiration and growth; in the other stage, however, viruses enter living plant, animal, or bacterial cells and make use of the host cell's chemical energy and its protein- and nucleic acid-synthesizing ability to replicate themselves.

The existence of submicroscopic infectious agents was suspected by the end of the 19th cent.; in 1892 the Russian botanist Dimitri Iwanowski showed that the sap from tobacco plants infected with mosaic disease, even after being passed through a porcelain filter known to retain all bacteria, contained an agent that could infect other tobacco plants. In 1900 a similarly filterable agent was reported for foot-and-mouth disease of cattle. In 1935 the American virologist W. M. Stanley crystallized tobacco mosaic virus; for that work Stanley shared the 1946 Nobel Prize in Chemistry with J. H. Northrup and J. B. Summer. Later studies of virus crystals established that the crystals were composed of individual virus particles, or virions. By the early 21st cent. the understanding of viruses had grown to the point where scientists synthesized (2002) a strain of poliovirus using their knowledge of that virus's genetic code and chemical components required.

Viral Structure

Typically the protein coat, or capsid, of an individual virus particle, or virion, is composed of multiple copies of one or several types of protein subunits, or capsomeres. Some viruses contain enzymes, and some have an outer membranous envelope. Many viruses have striking geometrically regular shapes, with helical structure as in tobacco mosaic virus, polyhedral (often icosahedral) symmetry as in herpes virus, or more complex mixtures of arrangements as in large viruses, such as the pox viruses and the larger bacterial viruses, or bacteriophages. Certain viruses, such as bacteriophages, have complex protein tails. The inner viral genetic material-the nucleic acid-may be double stranded, with two complementary strands, or single stranded; it may be deoxyribonucleic acid (DNA) or ribonucleic acid (RNA). The nucleic acid specifies information for the synthesis of from a few to 50 different proteins, depending on the type of virus.

Viral Infection of a Host Cell

A free virus particle may be thought of as a packaging device by which viral genetic material can be introduced into appropriate host cells, which the virus can recognize by means of proteins on its outermost surface. A bacterial virus infects the cell by attaching fibers of its protein tail to a specific receptor site on the bacterial cell wall and then injecting the nucleic acid into the host, leaving the empty capsid outside. In viruses with a membrane envelope the nucleocapsid (capsid plus nucleic acid) enters the cell cytoplasm by a process in which the viral envelope merges with a host cell membrane, often the membrane delimiting an endocytic structure (see endocytosis) in which the virus has been engulfed.

Within the cell the virus nucleic acid uses the host machinery to make copies of the viral nucleic acid as well as enzymes needed by the virus and coats and enveloping proteins, the coat proteins of the virus. The details of the process by which the information in viral nucleic acid is expressed and the sites in the cell where the virus locates vary according to the type of nucleic acid the virus contains and other viral features. As viral components are formed within a host cell, virions are created by a self-assembly process; that is, capsomere subunits spontaneously assemble into a protein coat around the nucleic core. Release of virus particles from the host may occur by lysis of the host cell, as in bacteria, or by budding from the host cell's surface that provides the envelope of membrane-enveloped forms.

Some viruses do not kill host cells but rather persist within them in one form or another. For example, certain of the viruses that can transform cells into a cancerous state (see cancer) are retroviruses; their genetic material is RNA but they carry an enzyme that can copy the RNA's information into DNA molecules, which then can integrate into the genetic apparatus of the host cell and reside there, generating corresponding products via host cell machinery. Similarly, in bacterial DNA viruses known as temperate phages, the viral nucleic acid becomes integrated into the host cell chromosomal material, a condition known as lysogeny; lysogenic phages are similar in many ways to genetic particles in bacterial cells called episomes (see recombination).

Viral Diseases

Some human diseases are apparently caused by the body's response to virus infection: immune reaction to altered virus-infected cells, release by infected cells of inflammatory substances, or circulation in the body of virus-antibody complexes are all virus-caused immunological disorders. Viruses cause many diseases of economically important animals and plants, some transmitted by carriers such as insects. A retrovirus (HIV) causes AIDS, several viruses (e.g. Epstein-Barr virus, human papillomavirus) cause particular forms of cancer in humans, and many have been shown to cause tumors in animals. Other viruses that infect humans cause measles, mumps, smallpox, yellow fever, rabies, poliomyelitis, influenza, and the common cold.

The techniques of molecular biology and genetic engineering have made possible the development of antiviral drugs effective against a variety of viral infections. Viruses, like bacterial infective agents, act as antigens in the body and elicit formation of antibodies in an infected individual (see immunity). Indeed, vaccines against viral diseases such as smallpox were developed before the causative agents were known. Some viruses stimulate cellular production of a protein, called interferon, that inhibits viral growth within the infected cell.

Classification

Viruses are not usually classified into conventional taxonomic groups but are usually grouped according to such properties as size, the type of nucleic acid they contain, the structure of the capsid and the number of protein subunits in it, host species, and immunological characteristics.


Biology Q&A: What is a virus?
Top

A virus is an infectious, protein-coated fragment of DNA or RNA. Viruses replicate by invading host cells and taking over the cell's "machinery" for DNA replication. Viral particles can then break out of the cells, spreading disease.

Previous question: What is anthrax?
Next question: Are viruses living organisms?


(veye-ruhs)

plur. viruses

Microorganisms consisting of DNA and RNA molecules wrapped in a protective coating of proteins. Viruses are the most primitive form of life. They depend on other living cells for their reproduction and growth. (See under “Medicine and Health.”)

  • Viruses cause many diseases. (See viral infection.)
  • Health Dictionary: virus
    Top
    (veye-ruhs)

    plur. viruses

    A minute organism that consists of a core of nucleic acid surrounded by protein. Viruses, which are so small that a special kind of microscope is needed to view them, can grow and reproduce only inside living cells. (See under “Life Sciences.”)

    Any member of a unique class of infectious agents, which were originally distinguished by their smallness (hence, they were described as ‘filtrable’ because of their ability to pass through bacteria-retaining filters) and their inability to replicate outside of a living host cell; because these properties are shared by certain bacteria (rickettsiae, chlamydiae), viruses are further characterized by their simple organization and their unique mode of replication. A virus consists of genetic material, which may be either DNA or RNA, and is surrounded by a protein coat and, in some viruses, by a membranous envelope.
    For a list of animal viruses and their classification
    Unlike cellular organisms, viruses do not contain all the biochemical mechanisms for their own replication; viruses replicate by using the biochemical mechanisms of a host cell to synthesize and assemble their separate components. When a complete virus particle (virion) comes in contact with a host cell, the viral nucleic acid and, in some viruses, a few enzymes are introduced into the host cell.
    Viruses vary in their stability; some such as poxviruses, parvoviruses and rotaviruses are very stable and survive well outside the body while others, particularly those viruses that are enveloped, such as herpesvirus, influenza virus, do not survive well and therefore usually require close contact for transmission and are readily destroyed by disinfectants, particularly those with a detergent action. Some viruses produce acute disease while others, sometimes referred to as slow viruses, such as retroviruses and lentiviruses and the scrapie agent, produce diseases which progress often to death over many years. Viruses in several families are transmitted by arthropod vectors.

    • v. amplification — see replication.
    • arbor v. — an incorrect, obsolete term for arbovirus.
    • attenuated v. — one whose pathogenicity has been reduced by serial animal passage or other means. See also attenuation (2).
    • avianized v. — see avianized.
    • bacterial v. — one that is capable of producing transmissible lysis of bacteria. See also bacteriophage.
    • C-type v. — see c-type virus.
    • Coxsackie v. — coxsackievirus.
    • defective v. — one that cannot be completely replicated or cannot form a protein coat or envelope; in some cases replication can proceed if missing gene functions are supplied by other viruses, termed helper virus (see below).
    • ECHO v. — see echovirus.
    • enteric v. — see enterovirus.
    • enteric orphan v's — orphan viruses isolated from the intestinal tract but not known to cause disease, hence orphan.
    • feline sarcoma v. — see feline sarcoma virus.
    • filterable v., filtrable v. — a pathogenic agent capable of passing through fine filters able to exclude bacteria; outdated terminology.
    • fixed v., v. fixé — rabies virus whose virulence and incubation period have been stabilized by serial passage and have remained fixed during further transmission; used for inoculating animals from which rabies vaccine is prepared.
    • foaming v. — feline syncytia-forming virus (FeSFV). So called because it causes foamy degeneration in feline cell cultures.
    • helper v. — one that aids in the development of a defective virus by supplying or restoring the activity of the viral gene such as that forming the protein coat.
    • herpes v. — herpesvirus.
    • human hepatitis v. — infection of chimpanzees with some of the human hepatitis viruses can result in infection of human workers.
    • influenza v. — any of a group of orthomyxoviruses that causes influenza. See influenza.
    • latent v. — a noninfective state and is demonstrable by indirect methods that activate it.
    • lytic v. — one that is replicated in the host cell and causes death and lysis of the cell.
    • masked v. — latent virus.
    • v. N — a type A influenza virus found in birds.
    • v. neutralization — see neutralization tests.
    • occult v. — see occult virus.
    • orphan v. — see orphan virus.
    • parainfluenza v. — see parainfluenzavirus.
    • pox v. — see pox.
    • rabies v. — an RNA virus of the rhabdovirus group that causes rabies.
    • respiratory syncytial v. — see paramyxoviridae.
    • slow v. — the name given to certain viruses that cause diseases characterized by a long incubation period and a very prolonged clinical course, e.g. the lentiviruses of sheep, maedi and visna.
    • street v. — rabies virus from a naturally infected animal, as opposed to a laboratory-adapted, fixed virus.

    A type of disease organism that causes a streaky discoloration of leaves or petals, distorts buds and new growth, and weakens plants.

    Wikipedia: Virus
    Top
    Viruses
    Rotavirus
    Virus classification
    Group: I–VII
    Groups

    I: dsDNA viruses
    II: ssDNA viruses
    III: dsRNA viruses
    IV: (+)ssRNA viruses
    V: (−)ssRNA viruses
    VI: ssRNA-RT viruses
    VII: dsDNA-RT viruses

    A virus (from the Latin virus meaning toxin or poison) is a small infectious agent that can only replicate inside the cells of another organism. Viruses are too small to be seen directly with a light microscope. Viruses infect all types of organisms, from animals and plants to bacteria and archaea.[1] Since the initial discovery of tobacco mosaic virus by Martinus Beijerinck in 1898,[2] about 5,000 of them have been described in detail,[3] although there are millions of different types of viruses.[4] Viruses are found in almost every ecosystem on Earth and these minute structures are the most abundant type of biological entity.[5][6] The study of viruses is known as virology, a sub-specialty of microbiology.

    Unlike prions and viroids, viruses consist of two or three parts: all viruses have genes made from either DNA or RNA, long molecules that carry genetic information; all have a protein coat that protects these genes; and some have an envelope of fat that surrounds them when they are outside a cell. Viroids do not have a protein coat and prions contain no RNA or DNA. Viruses vary from simple helical and icosahedral shapes, to more complex structures. Most viruses are about one hundred times smaller than an average bacterium. The origins of viruses in the evolutionary history of life are unclear: some may have evolved from plasmids—pieces of DNA that can move between cells—while others may have evolved from bacteria. In evolution, viruses are an important means of horizontal gene transfer, which increases genetic diversity.[7]

    Viruses spread in many ways; plant viruses are often transmitted from plant to plant by insects that feed on sap, such as aphids, while animal viruses can be carried by blood-sucking insects. These disease-bearing organisms are known as vectors. Influenza viruses are spread by coughing and sneezing. The norovirus and rotaviruses, common causes of viral gastroenteritis, are transmitted by the faecal-oral route and are passed from person to person by contact, entering the body in food or water. HIV is one of several viruses transmitted through sexual contact or by exposure to infected blood.

    Viral infections in animals provoke an immune response that usually eliminates the infecting virus. These immune responses can also be produced by vaccines, which give immunity to specific viral infections. However, some viruses including HIV and those causing viral hepatitis evade these immune responses and cause chronic infections. Microorganisms also have defences against viral infection, such as restriction modification systems.
    Antibiotics have no effect on viruses, but a few antiviral drugs have been developed. However, there are relatively few antivirals because there are few targets for these drugs to interfere with. This is because a virus reprograms its host's cells to make new viruses and almost all the proteins used in this process are normal parts of the body, with only a few viral proteins.

    Contents

    Etymology

    The word is from the Latin virus referring to poison and other noxious substances, first used in English in 1392.[8] Virulent, from Latin virulentus (poisonous), dates to 1400.[9] A meaning of "agent that causes infectious disease" is first recorded in 1728,[8] before the discovery of viruses by Dmitry Ivanovsky in 1892. The adjective viral dates to 1948.[10] The term virion is also used to refer to a single infective viral particle. The plural is "viruses".

    History

    An old, bespectacled man wearing a suit and sitting at a bench by a large window. The bench is covered with small bottles and test tubes. On the wall behind him is a large old-fashioned clock below which are four small enclosed shelves on which sit many neatly labelled bottles.
    Martinus Beijerinck in his laboratory in 1921

    In 1884, the French microbiologist Charles Chamberland invented a filter (known today as the Chamberland filter or Chamberland-Pasteur filter) with pores smaller than bacteria. Thus, he could pass a solution containing bacteria through the filter and completely remove them from the solution.[11] In 1892 the Russian biologist Dmitry Ivanovsky used this filter to study what is now known as tobacco mosaic virus. His experiments showed that the crushed leaf extracts from infected tobacco plants are still infectious after filtration. Ivanovsky suggested the infection might be caused by a toxin produced by bacteria, but did not pursue the idea.[12] At the time it was thought that all infectious agents could be retained by filters and grown on a nutrient medium—this was part of the germ theory of disease.[2] In 1898 the Dutch microbiologist Martinus Beijerinck repeated the experiments and became convinced that this was a new form of infectious agent.[13] He went on to observe that the agent multiplied only in dividing cells, but as his experiments did not show that it was made of particles, he called it a contagium vivum fluidum (soluble living germ) and re-introduced the word virus.[12] Beijerinck maintained that viruses were liquid in nature, a theory later discredited by Wendell Stanley, who proved they were particulate.[12] In the same year, 1899, Friedrich Loeffler and Frosch passed the agent of foot-and-mouth disease (aphthovirus) through a similar filter and ruled out the possibility of a toxin because of the high dilution; they concluded that the agent could replicate.[12]

    In the early 20th century, the English bacteriologist Frederick Twort discovered the viruses that infect bacteria, which are now called bacteriophages,[14] and the French-Canadian microbiologist Félix d'Herelle described viruses that, when added to bacteria on agar, would produce areas of dead bacteria. He accurately diluted a suspension of these viruses and discovered that the highest dilutions, rather than killing all the bacteria, formed discrete areas of dead organisms. Counting these areas and multiplying by the dilution factor allowed him to calculate the number of viruses in the suspension.[15]

    By the end of the nineteenth century, viruses were defined in terms of their infectivity, filterability, and their requirement for living hosts. Viruses had been grown only in plants and animals. In 1906, Harrison invented a method for growing tissue in lymph, and, in 1913, E. Steinhardt, C. Israeli, and R. A. Lambert used this method to grow vaccinia virus in fragments of guinea pig corneal tissue.[16] In 1928, H. B. Maitland and M. C. Maitland grew vaccinia virus in suspensions of minced hens' kidneys. Their method was not widely adopted until the 1950s, when poliovirus was grown on a large scale for vaccine production.[17]

    Another breakthrough came in 1931, when the American pathologist Ernest William Goodpasture grew influenza and several other viruses in fertilised chickens' eggs.[18] In 1949 John F. Enders, Thomas Weller, and Frederick Robbins grew polio virus in cultured human embryo cells, the first virus to be grown without using solid animal tissue or eggs. This work enabled Jonas Salk to make an effective polio vaccine.[19]

    With the invention of electron microscopy in 1931 by the German engineers Ernst Ruska and Max Knoll came the first images of viruses.[20] In 1935 American biochemist and virologist Wendell Stanley examined the tobacco mosaic virus and found it to be mostly made from protein.[21] A short time later, this virus was separated into protein and RNA parts.[22] Tobacco mosaic virus was the first one to be crystallised and whose structure could therefore be elucidated in detail. The first X-ray diffraction pictures of the crystallised virus were obtained by Bernal and Fankuchen in 1941. On the basis of her pictures, Rosalind Franklin discovered the full structure of the virus in 1955.[23] In the same year, Heinz Fraenkel-Conrat and Robley Williams showed that purified tobacco mosaic virus RNA and its coat protein can assemble by themselves to form functional viruses, suggesting that this simple mechanism was probably how viruses assembled within their host cells.[24]

    The second half of the twentieth century was the golden age of virus discovery and most of the 2,000 recognised species of animal, plant, and bacterial viruses were discovered during these years.[25][26] In 1957, equine arterivirus and the cause of Bovine virus diarrhea (a pestivirus) were discovered. In 1963, the hepatitis B virus was discovered by Baruch Blumberg,[27] and in 1965, Howard Temin described the first retrovirus. Reverse transcriptase, the key enzyme that retroviruses use to translate their RNA into DNA, was first described in 1970, independently by Howard Temin and David Baltimore.[28] In 1983 Luc Montagnier's team at the Pasteur Institute in France, first isolated the retrovirus now called HIV.[29]

    Origins

    Viruses are found wherever there is life and have probably existed since living cells first evolved.[30] The origin of viruses is unclear because they do not form fossils, so molecular techniques have been the most useful means of investigating how they arose.[31] These techniques rely on the availability of ancient viral DNA or RNA, but, unfortunately, most of the viruses that have been preserved and stored in laboratories are less than 90 years old.[32][33] There are three main hypotheses that try to explain the origins of viruses:[34][35]

    Regressive hypothesis 
    Viruses may have once been small cells that parasitised larger cells. Over time, genes not required by their parasitism were lost. The bacteria rickettsia and chlamydia are living cells that, like viruses, can reproduce only inside host cells. They lend support to this hypothesis, as their dependence on parasitism is likely to have caused the loss of genes that enabled them to survive outside a cell. This is also called the degeneracy hypothesis.[36][37]
    Cellular origin hypothesis 
    Some viruses may have evolved from bits of DNA or RNA that "escaped" from the genes of a larger organism. The escaped DNA could have come from plasmids (pieces of naked DNA that can move between cells) or transposons (molecules of DNA that replicate and move around to different positions within the genes of the cell).[38] Once called "jumping genes", transposons are examples of mobile genetic elements and could be the origin of some viruses. They were discovered in maize by Barbara McClintock in 1950.[39] This is sometimes called the vagrancy hypothesis.[36][40]
    Coevolution hypothesis 
    Viruses may have evolved from complex molecules of protein and nucleic acid at the same time as cells first appeared on earth and would have been dependent on cellular life for many millions of years. Viroids are molecules of RNA that are not classified as viruses because they lack a protein coat. However, they have characteristics that are common to several viruses and are often called subviral agents.[41] Viroids are important pathogens of plants.[42] They do not code for proteins but interact with the host cell and use the host machinery for their replication.[43] The hepatitis delta virus of humans has an RNA genome similar to viroids but has protein coat derived from hepatitis B virus and cannot produce one of its own. It is therefore a defective virus and cannot replicate without the help of hepatitis B virus.[44] Similarly, the virophage 'sputnik' is dependent on mimivirus, which infects the protozoan Acanthamoeba castellanii.[45] These viruses that are dependent on the presence of other virus species in the host cell are called satellites and may represent evolutionary intermediates of viroids and viruses.[46][47]

    Prions are infectious protein molecules that do not contain DNA or RNA.[48] They cause an infection in sheep called scrapie and cattle bovine spongiform encephalopathy ("mad cow" disease). In humans they cause kuru and Creutzfeldt-Jakob disease.[49] They are able to replicate because some proteins can exist in two different shapes and the prion changes the normal shape of a host protein into the prion shape. This starts a chain reaction where each prion protein converts many host proteins into more prions, and these new prions then go on to convert even more protein into prions. Although they are fundamentally different from viruses and viroids, their discovery gives credence to the idea that viruses could have evolved from self-replicating molecules.[50]

    Computer analysis of viral and host DNA sequences is giving a better understanding of the evolutionary relationships between different viruses and may help identify the ancestors of modern viruses. To date, such analyses have not helped to decide on which of these hypotheses are correct. However, it seems unlikely that all currently known viruses have a common ancestor and viruses have probably arisen numerous times in the past by one or more mechanisms.[51]

    Microbiology

    Life properties

    Opinions differ on whether viruses are a form of life, or organic structures that interact with living organisms. They have been described as "organisms at the edge of life",[52] since they resemble organisms in that they possess genes and evolve by natural selection,[53] and reproduce by creating multiple copies of themselves through self-assembly. Although they have genes, they do not have a cellular structure, which is often seen as the basic unit of life. Viruses do not have their own metabolism, and require a host cell to make new products. They therefore cannot reproduce outside a host cell (although bacterial species such as rickettsia and chlamydia are considered living organisms despite the same limitation). Accepted forms of life use cell division to reproduce, whereas viruses spontaneously assemble within cells. They differ from autonomous growth of crystals as they inherit genetic mutations while being subject to natural selection. Virus self-assembly within host cells has implications for the study of the origin of life, as it lends further credence to the hypothesis that life could have started as self-assembling organic molecules.[1]

    Structure

    A cartoon showing several identical molecules of protein forming a hexigon
    Diagram of how a virus capsid can be constructed using multiple copies of just two protein molecules

    Viruses display a wide diversity of shapes and sizes, called morphologies. Generally viruses are much smaller than bacteria. Most viruses that have been studied have a diameter between 10 and 300 nanometres. Some filoviruses have a total length of up to 1400 nm; their diameters are only about 80 nm.[54] Most viruses cannot be seen with a light microscope so scanning and transmission electron microscopes are used to visualise virions.[55] To increase the contrast between viruses and the background, electron-dense "stains" are used. These are solutions of salts of heavy metals, such as tungsten, that scatter the electrons from regions covered with the stain. When virions are coated with stain (positive staining), fine detail is obscured. Negative staining overcomes this problem by staining the background only.[56]

    A complete virus particle, known as a virion, consists of nucleic acid surrounded by a protective coat of protein called a capsid. These are formed from identical protein subunits called capsomers.[57] Viruses can have a lipid "envelope" derived from the host cell membrane. The capsid is made from proteins encoded by the viral genome and its shape serves as the basis for morphological distinction.[58][59] Virally coded protein subunits will self-assemble to form a capsid, generally requiring the presence of the virus genome. Complex viruses code for proteins that assist in the construction of their capsid. Proteins associated with nucleic acid are known as nucleoproteins, and the association of viral capsid proteins with viral nucleic acid is called a nucleocapsid. The capsid and entire virus structure can be mechanically (physically) probed through atomic force microscopy.[60][61] In general, there are four main morphological virus types:

    RNA coiled in a helix of repeating protein sub-units
    Electron micrograph of icosahedral adenovirus
    Herpes viruses have a lipid envelope
    Helical 
    These viruses are composed of a single type of capsomer stacked around a central axis to form a helical structure, which may have a central cavity, or hollow tube. This arrangement results in rod-shaped or filamentous virions: these can be short and highly rigid, or long and very flexible. The genetic material, generally single-stranded RNA, but ssDNA in some cases, is bound into the protein helix by interactions between the negatively charged nucleic acid and positive charges on the protein. Overall, the length of a helical capsid is related to the length of the nucleic acid contained within it and the diameter is dependent on the size and arrangement of capsomers. The well-studied Tobacco mosaic virus is an example of a helical virus.[62]
    Icosahedral 
    Most animal viruses are icosahedral or near-spherical with icosahedral symmetry. A regular icosahedron is the optimum way of forming a closed shell from identical sub-units. The minimum number of identical capsomers required is twelve, each composed of five identical sub-units. Many viruses, such as rotavirus, have more than twelve capsomers and appear spherical but they retain this symmetry. Capsomers at the apices are surrounded by five other capsomers and are called pentons. Capsomers on the triangular faces are surround by six others and are call hexons.[63]
    Envelope 
    Some species of virus envelope themselves in a modified form of one of the cell membranes, either the outer membrane surrounding an infected host cell, or internal membranes such as nuclear membrane or endoplasmic reticulum, thus gaining an outer lipid bilayer known as a viral envelope. This membrane is studded with proteins coded for by the viral genome and host genome; the lipid membrane itself and any carbohydrates present originate entirely from the host. The influenza virus and HIV use this strategy. Most enveloped viruses are dependent on the envelope for their infectivity.[64]
    Complex 
    These viruses possess a capsid that is neither purely helical, nor purely icosahedral, and that may possess extra structures such as protein tails or a complex outer wall. Some bacteriophages, such as Enterobacteria phage T4 have a complex structure consisting of an icosahedral head bound to a helical tail, which may have a hexagonal base plate with protruding protein tail fibres. This tail structure acts like a molecular syringe, attaching to the bacterial host and then injecting the viral genome into the cell.[65]

    The poxviruses are large, complex viruses that have an unusual morphology. The viral genome is associated with proteins within a central disk structure known as a nucleoid. The nucleoid is surrounded by a membrane and two lateral bodies of unknown function. The virus has an outer envelope with a thick layer of protein studded over its surface. The whole virion is slightly pleiomorphic, ranging from ovoid to brick shape.[66] Mimivirus is the largest known virus, with a capsid diameter of 400 nm. Protein filaments measuring 100 nm project from the surface. The capsid appears hexagonal under an electron microscope, therefore the capsid is probably icosahedral.[67]

    Some viruses that infect Archaea have complex structures that are unrelated to any other form of virus, with a wide variety of unusual shapes, ranging from spindle-shaped structures, to viruses that resemble hooked rods, teardrops or even bottles. Other archaeal viruses resemble the tailed bacteriophages, and can have multiple tail structures.[68]

    Genome

    Genomic diversity among viruses
    Property Parameters
    Nucleic acid
    • DNA
    • RNA
    • Both DNA and RNA (at different stages in the life cycle)
    Shape
    • Linear
    • Circular
    • Segmented
    Strandedness
    • Single-stranded
    • Double-stranded
    • Double-stranded with regions of single-strandedness
    Sense
    • Positive sense (+)
    • Negative sense (−)
    • Ambisense (+/−)

    An enormous variety of genomic structures can be seen among viral species; as a group they contain more structural genomic diversity than plants, animals, archaea, or bacteria. There are millions of different types of viruses;[4], though only about 5,000 of them have been described in detail.[3] A virus has either DNA or RNA genes and is called a DNA virus or a RNA virus respectively. By far most viruses have RNA. Plant viruses tend to have single-stranded RNA and bacteriophages tend to have double-stranded DNA.[69]

    Viral genomes are circular, such as polyomaviruses, or linear, such as adenoviruses. The type of nucleic acid is irrelevant to the shape of the genome. Among RNA viruses, the genome is often divided up into separate parts within the virion and is called segmented. Each segment often codes for one protein and they are usually found together in one capsid. Every segment is not required to be in the same virion for the overall virus to be infectious, as demonstrated by the brome mosaic virus.[54]

    A viral genome, irrespective of nucleic acid type, is either single-stranded or double-stranded. Single-stranded genomes consist of an unpaired nucleic acid, analogous to one-half of a ladder split down the middle. Double-stranded genomes consist of two complementary paired nucleic acids, analogous to a ladder. Some viruses, such as those belonging to the Hepadnaviridae, contain a genome that is partially double-stranded and partially single-stranded.[69]

    For viruses with RNA or single-stranded DNA, the strands are said to be either positive-sense (called the plus-strand) or negative-sense (called the minus-strand), depending on whether it is complementary to the viral messenger RNA (mRNA). Positive-sense viral RNA is identical to viral mRNA and thus can be immediately translated by the host cell. Negative-sense viral RNA is complementary to mRNA and thus must be converted to positive-sense RNA by an RNA polymerase before translation. DNA nomenclature is similar to RNA nomenclature, in that the coding strand for the viral mRNA is complementary to it (−), and the non-coding strand is a copy of it (+).[69]

    Genome size varies greatly between species. The smallest viral genomes code for only four proteins and have a mass of about 106 Daltons; the largest have a mass of about 108 Daltons and code for over one hundred proteins.[69] RNA viruses generally have smaller genome sizes than DNA viruses because of a higher error-rate when replicating, and have a maximum upper size limit. Beyond this limit, errors in the genome when replicating render the virus useless or uncompetitive. To compensate for this, RNA viruses often have segmented genomes where the genome is split into smaller molecules, thus reducing the chance of error. In contrast, DNA viruses generally have larger genomes because of the high fidelity of their replication enzymes.[70]

    A cartoon showing how viral genes can be shuffled to form new viruses
    How antigenic shift, or reassortment, can result in novel and highly pathogenic strains of human influenza

    Viruses undergo genetic change by several mechanisms. These include a process called genetic drift where individual bases in the DNA or RNA mutate to other bases. Most of these point mutations are "silent"—they do not change the protein that the gene encodes—but others can confer evolutionary advantages such as resistance to antiviral drugs.[71] Antigenic shift occurs when there is a major change in the genome of the virus. This can be a result of recombination or reassortment. When this happens with influenza viruses, pandemics might result.[72] RNA viruses often exist as quasispecies or swarms of viruses of the same species but with slightly different genome nucleoside sequences. Such quasispecies are a prime target for natural selection.[73]

    Segmented genomes confer evolutionary advantages; different strains of a virus with a segmented genome can shuffle and combine genes and produce progeny viruses or (offspring) that have unique characteristics. This is called reassortment or viral sex.[74]

    Genetic recombination is the process by which a strand of DNA is broken and then joined to the end of a different DNA molecule. This can occur when viruses infect cells simultaneously and studies of viral evolution have shown that recombination has been rampant in the species studied.[75] Recombination is common to both RNA and DNA viruses.[76][77]

    Replication cycle

    Viral populations do not grow through cell division, because they are acellular; instead, they use the machinery and metabolism of a host cell to produce multiple copies of themselves, and they assemble in the cell.

    A typical virus replication cycle
     
    Some bacteriophages inject their genomes into bacterial cells

    The life cycle of viruses differs greatly between species but there are six basic stages in the life cycle of viruses:[78]

    • Attachment is a specific binding between viral capsid proteins and specific receptors on the host cellular surface. This specificity determines the host range of a virus. For example, HIV infects only human T cells, because its surface protein, gp120, can interact with CD4 and receptors on the T cell's surface. This mechanism has evolved to favour those viruses that only infect cells in which they are capable of replication. Attachment to the receptor can induce the viral-envelope protein to undergo changes that results in the fusion of viral and cellular membranes.
    • Penetration follows attachment; viruses enter the host cell through receptor mediated endocytosis or membrane fusion. This is often called viral entry. The infection of plant cells is different from that of animal cells. Plants have a rigid cell wall made of cellulose and viruses can only get inside the cells after trauma to the cell wall.[79] Viruses such as tobacco mosaic virus can also move directly in plants, from cell to cell, through pores called plasmodesmata.[80] Bacteria, like plants, have strong cell walls that a virus must breach to infect the cell. Some viruses have evolved mechanisms that inject their genome into the bacterial cell while the viral capsid remains outside.[81]
    • Uncoating is a process in which the viral capsid is degraded by viral enzymes or host enzymes thus releasing the viral genomic nucleic acid.
    • Replication involves synthesis of viral messenger RNA (mRNA) for viruses except positive sense RNA viruses (see above), viral protein synthesis and assembly of viral proteins and viral genome replication.
    • Following the assembly of the virus particles, post-translational modification of the viral proteins often occurs. In viruses such as HIV, this modification, (sometimes called maturation), occurs after the virus has been released from the host cell.[82]
    • Viruses are released from the host cell by lysis—a process that kills the cell by bursting its membrane. Enveloped viruses (e.g., HIV) typically are released from the host cell by budding. During this process the virus acquires its envelope, which is a modified piece of the host's plasma membrane.

    The genetic material within viruses, and the method by which the material is replicated, vary between different types of viruses.

    DNA viruses 
    The genome replication of most DNA viruses takes place in the cell's nucleus. If the cell has the appropriate receptor on its surface, these viruses enter the cell by fusion with the cell membrane or by endocytosis. Most DNA viruses are entirely dependent on the host cell's DNA and RNA synthesising machinery, and RNA processing machinery. The viral genome must cross the cell's nuclear membrane to access this machinery.[83]
    RNA viruses 
    These viruses are unique because their genetic information is encoded in RNA. Replication usually takes place in the cytoplasm. RNA viruses can be placed into about four different groups depending on their modes of replication. The polarity (whether or not it can be used directly to make proteins) of the RNA largely determines the replicative mechanism, and whether the genetic material is single-stranded or double-stranded. RNA viruses use their own RNA replicase enzymes to create copies of their genomes.[84]
    Reverse transcribing viruses 
    These replicate using reverse transcription, which is the formation of DNA from an RNA template. Reverse transcribing viruses containing RNA genomes use a DNA intermediate to replicate, whereas those containing DNA genomes use an RNA intermediate during genome replication. Both types use the reverse transcriptase enzyme to carry out the nucleic acid conversion. Retroviruses often integrate the DNA produced by reverse transcription into the host genome. They are susceptible to antiviral drugs that inhibit the reverse transcriptase enzyme, e.g. zidovudine and lamivudine. An example of the first type is HIV, which is a retrovirus. Examples of the second type are the Hepadnaviridae, which includes Hepatitis B virus.[85]

    Effects on the host cell

    The range of structural and biochemical effects that viruses have on the host cell is extensive.[86] These are called cytopathic effects.[87] Most virus infections eventually result in the death of the host cell. The causes of death include cell lysis, alterations to the cell's surface membrane and apoptosis.[88] Often cell death is caused by cessation of its normal activities because of suppression by virus-specific proteins, not all of which are components of the virus particle.[89]

    Some viruses cause no apparent changes to the infected cell. Cells in which the virus is latent and inactive show few signs of infection and often function normally.[90] This causes persistent infections and the virus is often dormant for many months or years. This is often the case with herpes viruses.[91][92] Some viruses, such as Epstein-Barr virus, can cause cells to proliferate without causing malignancy,[93] while others, such as papillomaviruses, are established causes of cancer.[94]

    Classification

    Classification seeks to describe the diversity of viruses by naming and grouping them on the basis of similarities. In 1962, André Lwoff, Robert Horne, and Paul Tournier were the first to develop a means of virus classification, based on the Linnaean hierarchical system.[95] This system bases classification on phylum, class, order, family, genus, and species. Viruses were grouped according to their shared properties (not those of their hosts) and the type of nucleic acid forming their genomes.[96] Later the International Committee on Taxonomy of Viruses was formed.

    ICTV classification

    The International Committee on Taxonomy of Viruses (ICTV) developed the current classification system and wrote guidelines that put a greater weight on certain virus properties to maintain family uniformity. A unified taxonomy (a universal system for classifying viruses) has been established. The 7th lCTV Report formalised for the first time the concept of the virus species as the lowest taxon (group) in a branching hierarchy of viral taxa.[97] However, at present only a small part of the total diversity of viruses has been studied, with analyses of samples from humans finding that about 20% of the virus sequences recovered have not been seen before, and samples from the environment, such as from seawater and ocean sediments, finding that the large majority of sequences are completely novel.[98]

    The general taxonomic structure is as follows:

    Order (-virales)
    Family (-viridae)
    Subfamily (-virinae)
    Genus (-virus)
    Species (-virus)

    In the current (2008) ICTV taxonomy, five orders have been established, the Caudovirales, Herpesvirales, Mononegavirales, Nidovirales, and Picornavirales. The committee does not formally distinguish between subspecies, strains, and isolates. In total there are 5 orders, 82 families, 11 subfamilies, 307 genera, 2,083 species and about 3,000 types yet unclassified.[99][100]

    Baltimore classification

    A diagram showing how the Baltimore Classification is based on a virus's DNA or RNA and method of mRNA synthesis
    The Baltimore Classification of viruses is based on the method of viral mRNA synthesis.

    The Nobel Prize-winning biologist David Baltimore devised the Baltimore classification system.[28][101] The ICTV classification system is used in conjunction with the Baltimore classification system in modern virus classification.[102][103][104]

    The Baltimore classification of viruses is based on the mechanism of mRNA production. Viruses must generate mRNAs from their genomes to produce proteins and replicate themselves, but different mechanisms are used to achieve this in each virus family. Viral genomes may be single-stranded (ss) or double-stranded (ds), RNA or DNA, and may or may not use reverse transcriptase (RT). Additionally, ssRNA viruses may be either sense (+) or antisense (−). This classification places viruses into seven groups:

    As an example of viral classification, the chicken pox virus, varicella zoster (VZV), belongs to the order Herpesvirales, family Herpesviridae, subfamily Alphaherpesvirinae, and genus Varicellovirus. VZV is in Group I of the Baltimore Classification because it is a dsDNA virus that does not use reverse transcriptase.

    Viruses and human disease

    Overview of the main types of viral infection and the most notable species involved.[105] [106]

    Examples of common human diseases caused by viruses include the common cold, influenza, chickenpox and cold sores. Many serious diseases such as ebola, AIDS, avian influenza and SARS are caused by viruses. The relative ability of viruses to cause disease is described in terms of virulence. Other diseases are under investigation as to whether they too have a virus as the causative agent, such as the possible connection between human herpes virus six (HHV6) and neurological diseases such as multiple sclerosis and chronic fatigue syndrome. There is controversy over whether the borna virus, previously thought to cause neurological diseases in horses, could be responsible for psychiatric illnesses in humans.[107]

    Viruses have different mechanisms by which they produce disease in an organism, which largely depends on the viral species. Mechanisms at the cellular level primarily include cell lysis, the breaking open and subsequent death of the cell. In multicellular organisms, if enough cells die the whole organism will start to suffer the effects. Although viruses cause disruption of healthy homeostasis, resulting in disease, they may exist relatively harmlessly within an organism. An example would include the ability of the herpes simplex virus, which causes cold sores, to remain in a dormant state within the human body. This is called latency[108] and is a characteristic of the all herpes viruses including the Epstein-Barr virus, which causes glandular fever, and the varicella zoster virus, which causes chickenpox. Most people have been infected with at least one of these types of herpes virus.[109] However, these latent viruses might sometimes be beneficial, as the presence of the virus can increase immunity against bacterial pathogens, such as Yersinia pestis.[110] On the other hand, latent chickenpox infections return in later life as the disease called shingles.

    Some viruses can cause life-long or chronic infections, where the viruses continue to replicate in the body despite the host's defence mechanisms.[111] This is common in hepatitis B virus and hepatitis C virus infections. People chronically infected are known as carriers, as they serve as reservoirs of infectious virus.[112] In populations with a high proportion of carriers, the disease is said to be endemic.[113] In contrast to acute lytic viral infections this persistence implies compatible interactions with the host organism. Persistent viruses may even broaden the evolutionary potential of host species.[114]

    Epidemiology

    Viral epidemiology is the branch of medical science that deals with the transmission and control of virus infections in humans. Transmission of viruses can be vertical, that is from mother to child, or horizontal, which means from person to person. Examples of vertical transmission include hepatitis B virus and HIV where the baby is born already infected with the virus.[115] Another, more rare, example is the varicella zoster virus, which although causing relatively mild infections in humans, can be fatal to the foetus and newly born baby.[116] Horizontal transmission is the most common mechanism of spread of viruses in populations. Transmission can be exchange of blood by sexual activity, e.g. HIV, hepatitis B and hepatitis C; by mouth by exchange of saliva, e.g. Epstein-Barr virus, or from contaminated food or water, e.g. norovirus; by breathing in viruses in the form of aerosols, e.g. influenza virus; and by insect vectors such as mosquitoes, e.g. dengue. The rate or speed of transmission of viral infections depends on factors that include population density, the number of susceptible individuals, (i.e. those who are not immune),[117] the quality of health care and the weather.[118]

    Epidemiology is used to break the chain of infection in populations during outbreaks of viral diseases.[119] Control measures are used that are based on knowledge of how the virus is transmitted. It is important to find the source, or sources, of the outbreak and to identify the virus. Once the virus has been identified, the chain of transmission can sometimes be broken by vaccines. When vaccines are not available sanitation and disinfection can be effective. Often infected people are isolated from the rest of the community and those that have been exposed to the virus placed in quarantine.[120] To control the outbreak of foot and mouth disease in cattle in Britain in 2001, thousands of cattle were slaughtered.[121] Most viral infections of humans and other animals have incubation periods during which the infection causes no signs or symptoms.[122] Incubation periods for viral diseases range from a few days to weeks but are known for most infections.[123] Somewhat overlapping, but mainly following the incubation period, there is a period of communicability; a time when an infected individual or animal is contagious and can infect another person or animal.[124] This too is known for many viral infections and knowledge the length of both periods is important in the control of outbreaks.[125] When outbreaks cause an unusually high proportion of cases in a population, community or region they are called epidemics. If outbreaks spread worldwide they are called pandemics.[126]

    Epidemics and pandemics

    Native American populations were devastated by contagious diseases, particularly smallpox, brought to the Americas by European colonists. It is unclear how many Native Americans were killed by foreign diseases after the arrival of Columbus in the Americas, but the numbers have been estimated to be close to 70% of the indigenous population. The damage done by this disease significantly aided European attempts to displace and conquer the native population.[127]

    A pandemic is a worldwide epidemic. The 1918 flu pandemic, commonly referred to as the Spanish flu, was a category 5 influenza pandemic caused by an unusually severe and deadly influenza A virus. The victims were often healthy young adults, in contrast to most influenza outbreaks, which predominantly affect juvenile, elderly, or otherwise weakened patients.[128]

    The Spanish flu pandemic lasted from 1918 to 1919. Older estimates say it killed 40–50 million people,[129] while more recent research suggests that it may have killed as many as 100 million people, or 5% of the world's population in 1918.[130] Most researchers believe that HIV originated in sub-Saharan Africa during the twentieth century;[131] it is now a pandemic, with an estimated 38.6 million people now living with the disease worldwide.[132] The Joint United Nations Programme on HIV/AIDS (UNAIDS) and the World Health Organization (WHO) estimate that AIDS has killed more than 25 million people since it was first recognised on June 5, 1981, making it one of the most destructive epidemics in recorded history.[133] In 2007 there were 2.7 million new HIV infections and 2 million HIV-related deaths.[134]

    Several highly lethal viral pathogens are members of the Filoviridae. Filoviruses are filament-like viruses that cause viral hemorrhagic fever, and include the ebola and marburg viruses. The Marburg virus attracted widespread press attention in April 2005 for an outbreak in Angola. Beginning in October 2004 and continuing into 2005, the outbreak was the world's worst epidemic of any kind of viral hemorrhagic fever.[135]

    Cancer

    Viruses are an established cause of cancer in humans and other species. Viral cancers only occur in a minority of infected persons (or animals). Cancer viruses come from a range of virus families, including both RNA and DNA viruses, and so there is no single type of "oncovirus" (an obsolete term originally used for acutely transforming retroviruses). The development of cancer is determined by a variety of factors such as host immunity[136] and mutations in the host.[137] Viruses accepted to cause human cancers include some genotypes of human papillomavirus, hepatitis B virus, hepatitis C virus, Epstein-Barr virus, Kaposi's sarcoma-associated herpesvirus and human T-lymphotropic virus. The most recently discovered human cancer virus is a polyomavirus (Merkel cell polyomavirus) that causes most cases of a rare form of skin cancer called Merkel cell carcinoma.[138] Hepatitis viruses can develop into a chronic viral infection that leads to liver cancer.[139][140] Infection by human T-lymphotropic virus can lead to tropical spastic paraparesis and adult T-cell leukemia.[141] Human papillomaviruses are an established cause of cancers of cervix, skin, anus, and penis.[142] Within the Herpesviridae, Kaposi's sarcoma-associated herpesvirus causes Kaposi's sarcoma and body cavity lymphoma, and Epstein–Barr virus causes Burkitt's lymphoma, Hodgkin’s lymphoma, B lymphoproliferative disorder and nasopharyngeal carcinoma.[143] Merkel cell polyomavirus closely related to SV40 and mouse polyomaviruses that have been used as animal models for cancer viruses for over 50 years.[144]

    Host defence mechanisms

    The body's first line of defence against viruses is the innate immune system. This comprises cells and other mechanisms that defend the host from infection in a non-specific manner. This means that the cells of the innate system recognise, and respond to, pathogens in a generic way, but unlike the adaptive immune system, it does not confer long-lasting or protective immunity to the host.[145]

    RNA interference is an important innate defence against viruses.[146] Many viruses have a replication strategy that involves double-stranded RNA (dsRNA). When such a virus infects a cell, it releases its RNA molecule or molecules, which immediately bind to a protein complex called dicer that cuts the RNA into smaller pieces. A biochemical pathway called the RISC complex is activated, which degrades the viral mRNA and the cell survives the infection. Rotaviruses avoid this mechanism by not uncoating fully inside the cell and by releasing newly produced mRNA through pores in the particle's inner capsid. The genomic dsRNA remains protected inside the core of the virion.[147][148]

    When the adaptive immune system of a vertebrate encounters a virus, it produces specific antibodies that bind to the virus and render it non-infectious. This is called humoral immunity. Two types of antibodies are important. The first called IgM is highly effective at neutralizing viruses but is only produced by the cells of the immune system for a few weeks. The second, called, IgG is produced indefinitely. The presence of IgM in the blood of the host is used to test for acute infection, whereas IgG indicates an infection sometime in the past.[149] IgG antibody is measured when tests for immunity are carried out.[150]

    Two spherical rotavirus particles, one is coated with antibody which looks like many small birds, regularly spaced on the surface of the virus
    Two rotaviruses: the one on the right is coated with antibodies that stop its attaching to cells and infecting them

    A second defence of vertebrates against viruses is called cell-mediated immunity and involves immune cells known as T cells. The body's cells constantly display short fragments of their proteins on the cell's surface, and if a T cell recognises a suspicious viral fragment there, the host cell is destroyed by killer T cells and the virus-specific T-cells proliferate. Cells such as the macrophage are specialists at this antigen presentation.[151] The production of interferon is an important host defence mechanism. This is a hormone produced by the body when viruses are present. Its role in immunity is complex, but it eventually stops the viruses from reproducing by killing the infected cell and its close neighbours.[152]

    Not all virus infections produce a protective immune response in this way. HIV evades the immune system by constantly changing the amino acid sequence of the proteins on the surface of the virion. These persistent viruses evade immune control by sequestration, blockade of antigen presentation, cytokine resistance, evasion of natural killer cell activities, escape from apoptosis, and antigenic shift.[153] Other viruses, called neurotropic viruses, are disseminated by neural spread where the immune system may be unable to reach them.

    Prevention and treatment

    Because viruses use vital metabolic pathways within host cells to replicate, they are difficult to eliminate without using drugs that cause toxic effects to host cells in general. The most effective medical approaches to viral diseases are vaccinations to provide preventative immunity to infection, and antiviral drugs that selectively interfere with viral replication.

    Vaccines

    Vaccination is a cheap and effective way of preventing infections by viruses. Vaccines were used to prevent viral infections long before the discovery of the actual viruses. Their use has resulted in a dramatic decline in morbidity (illness) and mortality (death) associated with viral infections such as polio, measles, mumps and rubella.[154] Smallpox infections have been eradicated.[155] Vaccines are available to prevent over thirteen viral infections of humans,[156] and more are used to prevent viral infections of animals.[157] Vaccines can consist of live-attenuated or killed viruses, or viral proteins (antigens).[158] Live vaccines contain weakened forms of the virus that causes the disease. Such viruses are called attenuated. Live vaccines can be dangerous when given to people with a weak immunity, (who are described as immunocompromised), because in these people, the weakened virus can cause the original disease.[159] Biotechnology and genetic engineering techniques are used to produce subunit vaccines. These vaccines use only the capsid proteins of the virus. Hepatitis B vaccine is an example of this type of vaccine.[160] Subunit vaccines are safe for immunocompromised patients because they cannot cause the disease.[161] The yellow fever virus vaccine, a live-attenuated strain called 17D, is probably the safest and most effective vaccine ever generated.[162]

    Antiviral drugs

    The guanosine analogue Aciclovir

    Over the past twenty years, the development of antiviral drugs has increased rapidly. This has been driven by the AIDS pandemic. Antiviral drugs are often nucleoside analogues, (fake DNA building blocks), which viruses incorporate into their genomes during replication. The life-cycle of the virus is then halted because the newly synthesised DNA is inactive. This is because these analogues lack the hydroxyl groups, which, along with phosphorus atoms, link together to form the strong "backbone" of the DNA molecule. This is called DNA chain termination.[163] Examples of nucleoside analogues are aciclovir for Herpes simplex virus infections and lamivudine for HIV and Hepatitis B virus infections. Aciclovir is one of the oldest and most frequently prescribed antiviral drugs.[164] Other antiviral drugs in use target different stages of the viral life cycle. HIV is dependent on a proteolytic enzyme called the HIV-1 protease for it to become fully infectious. There is a large class of drugs called protease inhibitors that inactivate this enzyme.

    Hepatitis C is caused by an RNA virus. In 80% of people infected, the disease is chronic, and without treatment, they are infected for the remainder of their lives. However, there is now an effective treatment that uses the nucleoside analogue drug ribavirin combined with interferon.[165] The treatment of chronic carriers of the hepatitis B virus by using a similar strategy using lamivudine has been developed.[166]

    Infection in other species

    Viruses infect all cellular life and, although viruses occur universally, each cellular species has its own specific range that often infect only that species.[167] A few viruses called satellites are parasites of other viruses, since they can only replicate within cells that have already been infected by another virus.[168] Viruses are important pathogens of livestock. Diseases such as Foot and Mouth Disease and bluetongue are caused by viruses.[169] Companion animals such as cats, dogs, and horses, if not vaccinated, are susceptible to serious viral infections. Canine parvovirus is caused by a small DNA virus and infections are often fatal in pups.[170] Like all invertebrates, the honey bee is susceptible to many viral infections.[171] Fortunately, most viruses co-exist harmlessly in their host and cause no signs or symptoms of disease.[2]

    Plants

    A red pepper (Capsicum) with a brown bruise caused by viruses
    Peppers infected by mild mottle virus

    There are many types of plant virus, but often they cause only a loss of yield, and it is not economically viable to try to control them. Plant viruses are often spread from plant to plant by organisms, known as vectors. These are normally insects, but some fungi, nematode worms and single-celled organisms have been shown to be vectors. When control of plant virus infections is considered economical, for perennial fruits for example, efforts are concentrated on killing the vectors and removing alternate hosts such as weeds.[172] Plant viruses are harmless to humans and other animals because they can reproduce only in living plant cells.[173]

    Plants have elaborate and effective defence mechanisms against viruses. One of the most effective is the presence of so-called resistance (R) genes. Each R gene confers resistance to a particular virus by triggering localised areas of cell death around the infected cell, which can often be seen with the unaided eye as large spots. This stops the infection from spreading.[174] RNA interference is also an effective defence in plants.[175] When they are infected, plants often produce natural disinfectants that kill viruses, such as salicylic acid, nitric oxide, and reactive oxygen molecules.[176]

    Bacteria

    An electron micrograph showing a portion of a bacterium covered with viruses
    Transmission electron micrograph of multiple bacteriophages attached to a bacterial cell wall

    Bacteriophages are a common and diverse group of viruses and are the most abundant form of biological entity in aquatic environments—there are up to ten times more of these viruses in the oceans than there are bacteria,[177] reaching levels of 250,000,000 bacteriophages per millilitre of seawater.[178] These viruses infect specific bacteria by binding to surface receptor molecules and then entering the cell. Within a short amount of time, in some cases just minutes, bacterial polymerase starts translating viral mRNA into protein. These proteins go on to become either new virions within the cell, helper proteins, which help assembly of new virions, or proteins involved in cell lysis. Viral enzymes aid in the breakdown of the cell membrane, and, in the case of the T4 phage, in just over twenty minutes after injection over three hundred phages could be released.[179]

    The major way bacteria defend themselves from bacteriophages is by producing enzymes that destroy foreign DNA. These enzymes, called restriction endonucleases, cut up the viral DNA that bacteriophages inject into bacterial cells.[180] Bacteria also contain a system that uses CRISPR sequences to retain fragments of the genomes of viruses that the bacteria have come into contact with in the past, which allows them to block the virus's replication through a form of RNA interference.[181][182] This genetic system provides bacteria with acquired immunity to infection.

    Archaea

    Some viruses replicate within archaea: these are double-stranded DNA viruses with unusual and sometimes unique shapes.[5][68] These viruses have been studied in most detail in the thermophilic archaea, particularly the orders Sulfolobales and Thermoproteales.[183] Defences against these viruses may involve RNA interference from repetitive DNA sequences within archaean genomes that are related to the genes of the viruses.[184][185]

    Applications

    Life sciences and medicine

    Viruses are important to the study of molecular and cellular biology as they provide simple systems that can be used to manipulate and investigate the functions of cells.[186] The study and use of viruses have provided valuable information about aspects of cell biology.[187] For example, viruses have been useful in the study of genetics and helped our understanding of the basic mechanisms of molecular genetics, such as DNA replication, transcription, RNA processing, translation, protein transport, and immunology.

    Geneticists often use viruses as vectors to introduce genes into cells that they are studying. This is useful for making the cell produce a foreign substance, or to study the effect of introducing a new gene into the genome. In similar fashion, virotherapy uses viruses as vectors to treat various diseases, as they can specifically target cells and DNA. It shows promising use in the treatment of cancer and in gene therapy. Eastern European scientists have used phage therapy as an alternative to antibiotics for some time, and interest in this approach is increasing, because of the high level of antibiotic resistance now found in some pathogenic bacteria.[188]

    Materials science and nanotechnology

    Current trends in nanotechnology promise to make much more versatile use of viruses. From the viewpoint of a materials scientist, viruses can be regarded as organic nanoparticles. Their surface carries specific tools designed to cross the barriers of their host cells. The size and shape of viruses, and the number and nature of the functional groups on their surface, is precisely defined. As such, viruses are commonly used in materials science as scaffolds for covalently linked surface modifications. A particular quality of viruses is that they can be tailored by directed evolution. The powerful techniques developed by life sciences are becoming the basis of engineering approaches towards nanomaterials, opening a wide range of applications far beyond biology and medicine.[189]

    Because of their size, shape, and well-defined chemical structures, viruses have been used as templates for organizing materials on the nanoscale. Recent examples include work at the Naval Research Laboratory in Washington, DC, using Cowpea Mosaic Virus (CPMV) particles to amplify signals in DNA microarray based sensors. In this application, the virus particles separate the fluorescent dyes used for signalling to prevent the formation of non-fluorescent dimers that act as quenchers.[190] Another example is the use of CPMV as a nanoscale breadboard for molecular electronics.[191]

    Weapons

    The ability of viruses to cause devastating epidemics in human societies has led to the concern that viruses could be weaponised for biological warfare. Further concern was raised by the successful recreation of the infamous 1918 influenza virus in a laboratory.[192] The smallpox virus devastated numerous societies throughout history before its eradication. There are officially only two centers in the world which keep stocks of smallpox virus—the Russian Vector laboratory, and the United States Centers for Disease Control.[193] But fears that it may be used as a weapon are not totally unfounded;[193] the vaccine for smallpox is not safe—during the years before the eradication of smallpox disease more people became seriously ill as a result of vaccination than did people from smallpox[194] — and smallpox vaccination is no longer universally practiced.[195] Thus, much of the modern human population has almost no established resistance to smallpox.[193]

    References

    Notes

    1. ^ a b Koonin EV, Senkevich TG, Dolja VV (2006). "The ancient Virus World and evolution of cells". Biol. Direct 1: 29. doi:10.1186/1745-6150-1-29. PMID 16984643. PMC 1594570. http://www.biology-direct.com/content/1//29. Retrieved 14 September 2008. 
    2. ^ a b c Dimmock p. 4
    3. ^ a b Dimmock p. 49
    4. ^ a b Breitbart M, Rohwer F (June 2005). "Here a virus, there a virus, everywhere the same virus?". Trends Microbiol 13 (6): 278–84. doi:10.1016/j.tim.2005.04.003. PMID 15936660. 
    5. ^ a b Lawrence CM, Menon S, Eilers BJ, et al. (May 2009). "Structural and functional studies of archaeal viruses". J. Biol. Chem. 284 (19): 12599–603. doi:10.1074/jbc.R800078200. PMID 19158076. http://www.jbc.org/cgi/pmidlookup?view=long&pmid=19158076. 
    6. ^ Edwards RA, Rohwer F (June 2005). "Viral metagenomics". Nat. Rev. Microbiol. 3 (6): 504–10. doi:10.1038/nrmicro1163. PMID 15886693. 
    7. ^ Canchaya C, Fournous G, Chibani-Chennoufi S, Dillmann ML, Brüssow H (August 2003). "Phage as agents of lateral gene transfer". Curr. Opin. Microbiol. 6 (4): 417–24. doi:10.1016/S1369-5274(03)00086-9. PMID 12941415. 
    8. ^ a b "virus". The Online Etymology Dictionary. http://www.etymonline.com/index.php?term=virus. Retrieved 12 September 2008. 
    9. ^ "virulent, a.". The Oxford English Dictionary — Online. http://dictionary.oed.com. Retrieved 12 September 2008. 
    10. ^ "viral, a.". The Oxford English Dictionary — Online. http://dictionary.oed.com. Retrieved 12 September 2008. 
    11. ^ Shors pp. 76–77
    12. ^ a b c d Collier p. 3
    13. ^ Dimmock p.4–5
    14. ^ Shors p. 589
    15. ^ D'Herelle F (September 2007). "On an invisible microbe antagonistic toward dysenteric bacilli": brief note by Mr. F. D'Herelle, presented by Mr. Roux. 1917. Res. Microbiol. 158(7):553–4. Epub 2007 Jul 28. PMID 17855060
    16. ^ Steinhardt, E; Israeli, C; and Lambert, R.A. (1913) "Studies on the cultivation of the virus of vaccinia" J. Inf Dis. 13, 294–300
    17. ^ Collier p. 4
    18. ^ Goodpasture EW, Woodruff AM, Buddingh GJ (1931). "The cultivation of vaccine and other viruses in the chorioallantoic membrane of chick embryos". Science 74, pp. 371–372 PMID 17810781
    19. ^ Rosen FS (2004). "Isolation of poliovirus—John Enders and the Nobel Prize". New England Journal of Medicine, 351, pp. 1481–83 PMID 15470207
    20. ^ From Nobel Lectures, Physics 1981–1990, (1993) Editor-in-Charge Tore Frängsmyr, Editor Gösta Ekspång, World Scientific Publishing Co., Singapore.
      • In 1887, Buist visualised one of the largest, Vaccinia virus, by optical microscopy after staining it. Vaccinia was not known to be a virus at that time. (Buist J.B. Vaccinia and Variola: a study of their life history Churchill, London)
    21. ^ Stanley WM, Loring HS (1936). "The isolation of crystalline tobacco mosaic virus protein from diseased tomato plants". Science, 83, p.85 PMID 17756690
    22. ^ Stanley WM, Lauffer MA (1939). "Disintegration of tobacco mosaic virus in urea solutions". Science 88, pp. 345–347 PMID 17788438
    23. ^ Creager AN, Morgan GJ (June 2008). "After the double helix: Rosalind Franklin's research on Tobacco mosaic virus". Isis 99 (2): 239–72. doi:10.1086/588626. PMID 18702397. 
    24. ^ Dimmock p. 12
    25. ^ Norrby E (2008). "Nobel Prizes and the emerging virus concept". Arch. Virol. 153 (6): 1109–23. doi:10.1007/s00705-008-0088-8. PMID 18446425. 
    26. ^ ICTV list of virus discoveries and discoverers
    27. ^ Collier p. 745
    28. ^ a b Temin HM, Baltimore D (1972). "RNA-directed DNA synthesis and RNA tumor viruses". Adv. Virus Res. 17: 129–86. doi:10.1016/S0065-3527(08)60749-6. PMID 4348509. 
    29. ^ Barré-Sinoussi, F., Chermann, J. C., Rey, F., Nugeyre, M. T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vezinet-Brun, F., Rouzioux, C., Rozenbaum, W., and Montagnier, L. (1983). "Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)". Science 220 (4599): 868–871. doi:10.1126/science.6189183. PMID 6189183. 
    30. ^ Iyer LM, Balaji S, Koonin EV, Aravind L (April 2006). "Evolutionary genomics of nucleo-cytoplasmic large DNA viruses". Virus Res. 117 (1): 156–84. doi:10.1016/j.virusres.2006.01.009. PMID 16494962. http://linkinghub.elsevier.com/retrieve/pii/S0168-1702(06)00028-1. Retrieved 14 September 2008. 
    31. ^ Liu Y, Nickle DC, Shriner D, et al. (2004). "Molecular clock-like evolution of human immunodeficiency virus type 1". Virology. 10;329(1):101–8, PMID 15476878
    32. ^ Shors p. 16
    33. ^ Collier pp. 18–19
    34. ^ Shors pp. 14–16
    35. ^ Collier pp. 11–21
    36. ^ a b Dimmock p. 16
    37. ^ Collier p. 11
    38. ^ Shors p. 574
    39. ^ McClintock, B. (June 1950). "The origin and behavior of mutable loci in maize". Proc Natl Acad Sci U S A. 36 (6): 344–55. doi:10.1073/pnas.36.6.344. PMID 15430309. 
    40. ^ Collier pp. 11–12
    41. ^ Dimmock p. 55
    42. ^ Shors 551–3
    43. ^ Tsagris EM, de Alba AE, Gozmanova M, Kalantidis K (September 2008). "Viroids". Cell. Microbiol. 10 (11): 2168. doi:10.1111/j.1462-5822.2008.01231.x. PMID 18764915. http://www.blackwell-synergy.com/doi/abs/10.1111/j.1462-5822.2008.01231.x. Retrieved 19 September 2008. 
    44. ^ Shors p. 492–3
    45. ^ La Scola B, Desnues C, Pagnier I, Robert C, Barrassi L, Fournous G, Merchat M, Suzan-Monti M, Forterre P, Koonin E, Raoult D (September 2008). "The virophage as a unique parasite of the giant mimivirus". Nature 455 (7209): 100–4. doi:10.1038/nature07218. PMID 18690211. 
    46. ^ Collier p. 777
    47. ^ Dimmock p. 55–7
    48. ^ Liberski PP (2008). "Prion diseases: a riddle wrapped in a mystery inside an enigma". Folia Neuropathol 46 (2): 93–116. PMID 18587704. http://www.folianeuro.termedia.pl/showarticle.php?id=10625. Retrieved 19 September 2008. 
    49. ^ Dimmock pp. 57–58
    50. ^ Lupi O, Dadalti P, Cruz E, Goodheart C (2007). "Did the first virus self-assemble from self-replicating prion proteins and RNA?". Med. Hypotheses 69 (4): 724–30. doi:10.1016/j.mehy.2007.03.031. PMID 17512677. http://linkinghub.elsevier.com/retrieve/pii/S0306-9877(07)00261-7. Retrieved 19 September 2008. 
    51. ^ Dimmock pp. 15–16
    52. ^ Rybicki EP (1990) "The classification of organisms at the edge of life, or problems with virus systematics." S Aft J Sci 86:182–186
    53. ^ Holmes EC (October 2007). "Viral evolution in the genomic age". PLoS Biol. 5 (10): e278. doi:10.1371/journal.pbio.0050278. PMID 17914905. PMC 1994994. http://biology.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pbio.0050278. Retrieved 13 September 2008. 
    54. ^ a b Collier pp. 33–55
    55. ^ Collier pp. 33–37
    56. ^ Kiselev NA, Sherman MB, Tsuprun VL (1990). "Negative staining of proteins". Electron Microsc. Rev. 3 (1): 43–72. doi:10.1016/0892-0354(90)90013-I. PMID 1715774. 
    57. ^ Collier p. 40
    58. ^ Caspar DL, Klug A (1962). "Physical principles in the construction of regular viruses". Cold Spring Harb. Symp. Quant. Biol. 27: 1–24. PMID 14019094. 
    59. ^ Crick FH, Watson JD (1956). "Structure of small viruses". Nature 177 (4506): 473–5. doi:10.1038/177473a0. PMID 13309339. 
    60. ^ Falvo, M.R.; S. Washburn, R. Superfine, M. Finch, F.P. Brooks Jr, V. Chi, R.M. Taylor 2nd (March 1997). "Manipulation of individual viruses: friction and mechanical properties". Biophysical Journal 72 (3): 1396–1403. doi:10.1016/S0006-3495(97)78786-1. http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B94RW-4V9K7FD-1D&_user=108429&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000059713&_version=1&_urlVersion=0&_userid=108429&md5=d5aafeb39c5a05782d0935dc7ced27ad. Retrieved 8 May 2009. 
    61. ^ Kuznetsov, Yu. G.; A. J. Malkin, R. W. Lucas, M. Plomp, A. McPherson (1 September 2001). "Imaging of viruses by atomic force microscopy". J Gen Virol 82 (9): 2025–2034. http://vir.sgmjournals.org. Retrieved 19 April 2009. 
    62. ^ Collier p. 37
    63. ^ Collier pp. 40, 42
    64. ^ Collier pp. 42–43
    65. ^ Rossmann MG, Mesyanzhinov VV, Arisaka F, Leiman PG (April 2004). "The bacteriophage T4 DNA injection machine". Curr. Opin. Struct. Biol. 14 (2): 171–80. doi:10.1016/j.sbi.2004.02.001. PMID 15093831. 
    66. ^ Long GW, Nobel J, Murphy FA, Herrmann KL, Lourie B (September 1970). "Experience with electron microscopy in the differential diagnosis of smallpox". Appl Microbiol 20 (3): 497–504. PMID 4322005. 
    67. ^ Suzan-Monti M, La Scola B, Raoult D (2006). "Genomic and evolutionary aspects of Mimivirus". Virus Research 117 (1): 145–155. doi:10.1016/j.virusres.2005.07.011. PMID 16181700. 
    68. ^ a b Prangishvili D, Forterre P, Garrett RA (2006). "Viruses of the Archaea: a unifying view". Nat. Rev. Microbiol. 4 (11): 837–48. doi:10.1038/nrmicro1527. PMID 17041631. 
    69. ^ a b c d Collier pp. 96–99
    70. ^ Pressing J, Reanney DC (1984). "Divided genomes and intrinsic noise". J Mol Evol. 20(2):135–46.
    71. ^ Pan XP, Li LJ, Du WB, Li MW, Cao HC, Sheng JF (November 2007). "Differences of YMDD mutational patterns, precore/core promoter mutations, serum HBV DNA levels in lamivudine-resistant hepatitis B genotypes B and C". J. Viral Hepat. 14 (11): 767–74. doi:10.1111/j.1365-2893.2007.00869.x. PMID 17927612. http://www.blackwell-synergy.com/openurl?genre=article&sid=nlm:pubmed&issn=1352-0504&date=2007&volume=14&issue=11&spage=767. Retrieved 13 September 2008. 
    72. ^ Hampson AW, Mackenzie JS (November 2006). "The influenza viruses". Med. J. Aust. 185 (10 Suppl): S39–43. PMID 17115950. http://www.mja.com.au/public/issues/185_10_201106/ham10884_fm.html. Retrieved 13 September 2008. 
    73. ^ Metzner KJ (December 2006). "Detection and significance of minority quasispecies of drug-resistant HIV-1". J HIV Ther 11 (4): 74–81. PMID 17578210. 
    74. ^ Goudsmit, Jaap. Viral Sex. Oxford Univ Press, 1998.ISBN 9780195124965 ISBN 0195124960
    75. ^ Worobey M, Holmes EC (1999). "Evolutionary aspects of recombination in RNA viruses". J. Gen. Virol. 80 ( Pt 10): 2535–43. PMID 10573145. 
    76. ^ Lukashev AN (2005). "Role of recombination in evolution of enteroviruses". Rev. Med. Virol. 15 (3): 157–67. doi:10.1002/rmv.457. PMID 15578739. 
    77. ^ Umene K (1999). "Mechanism and application of genetic recombination in herpesviruses". Rev. Med. Virol. 9 (3): 171–82. doi:10.1002/(SICI)1099-1654(199907/09)9:3<171::AID-RMV243>3.0.CO;2-A. PMID 10479778. 
    78. ^ Collier pp. 75–91
    79. ^ Dimmock p. 70
    80. ^ Boevink P, Oparka KJ (August 2005). "Virus-host interactions during movement processes". Plant Physiol. 138 (4): 1815–21. doi:10.1104/pp.105.066761. PMID 16172094. PMC 1183373. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=16172094. 
    81. ^ Dimmock p. 71
    82. ^ Barman S, Ali A, Hui EK, Adhikary L, Nayak DP (2001). "Transport of viral proteins to the apical membranes and interaction of matrix protein with glycoproteins in the assembly of influenza viruses". Virus Res. 77 (1): 61–9. doi:10.1016/S0168-1702(01)00266-0. PMID 11451488. 
    83. ^ Shors p. 54; Collier p. 78
    84. ^ Collier p. 79
    85. ^ Collier pp. 88–89
    86. ^ Collier pp. 115–146
    87. ^ Collier p. 115
    88. ^ Roulston A, Marcellus RC, Branton PE (1999). "Viruses and apoptosis". Annu. Rev. Microbiol. 53: 577–628. doi:10.1146/annurev.micro.53.1.577. PMID 10547702. http://arjournals.annualreviews.org/doi/abs/10.1146/annurev.micro.53.1.577?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dncbi.nlm.nih.gov. Retrieved 20 December 2008. 
    89. ^ Alwine JC (2008). "Modulation of host cell stress responses by human cytomegalovirus". Curr. Top. Microbiol. Immunol. 325: 263–79. doi:10.1007/978-3-540-77349-8_15. PMID 18637511. 
    90. ^ Sinclair J (March 2008). "Human cytomegalovirus: Latency and reactivation in the myeloid lineage". J. Clin. Virol. 41 (3): 180–5. doi:10.1016/j.jcv.2007.11.014. PMID 18164651. http://linkinghub.elsevier.com/retrieve/pii/S1386-6532(07)00434-9. Retrieved 20 December 2008. 
    91. ^ Jordan MC, Jordan GW, Stevens JG, Miller G (June 1984). "Latent herpesviruses of humans". Ann. Intern. Med. 100 (6): 866–80. PMID 6326635. 
    92. ^ Sissons JG, Bain M, Wills MR (February 2002). "Latency and reactivation of human cytomegalovirus". J. Infect. 44 (2): 73–7. doi:10.1053/jinf.2001.0948. PMID 12076064. http://linkinghub.elsevier.com/retrieve/pii/S016344530190948X. Retrieved 20 December 2008. 
    93. ^ Barozzi P, Potenza L, Riva G, Vallerini D, Quadrelli C, Bosco R, Forghieri F, Torelli G, Luppi M (December 2007). "B cells and herpesviruses: a model of lymphoproliferation". Autoimmun Rev 7 (2): 132–6. doi:10.1016/j.autrev.2007.02.018. PMID 18035323. http://linkinghub.elsevier.com/retrieve/pii/S1568-9972(07)00061-4. Retrieved 20 December 2008. 
    94. ^ Subramanya D, Grivas PD (November 2008). "HPV and cervical cancer: updates on an established relationship". Postgrad Med 120 (4): 7–13. doi:10.3810/pgm.2008.11.1928. PMID 19020360. 
    95. ^ Lwoff A, Horne RW, Tournier P (1962). "A virus system" (in French). C. R. Hebd. Seances Acad. Sci. 254: 4225–7. PMID 14467544. 
    96. ^ Lwoff A, Horne R, Tournier P (1962). "A system of viruses". Cold Spring Harb. Symp. Quant. Biol. 27: 51–5. PMID 13931895. 
    97. ^ Fields p. 27
      • As defined therein, "a virus species is a polythetic class of viruses that constitute a replicating lineage and occupy a particular ecological niche". A “polythetic" class is one whose members have several properties in common, although they do not necessarily all share a single common defining one. Members of a virus species are defined collectively by a consensus group of properties. Virus species thus differ from the higher viral taxa, which are “universal” classes and as such are defined by properties that are necessary for membership.
    98. ^ Delwart EL (2007). "Viral metagenomics". Rev. Med. Virol. 17 (2): 115–31. doi:10.1002/rmv.532. PMID 17295196. 
    99. ^ Virus Taxonomy 2008. International Committee on Taxonomy of Viruses. Retrieved on September 15, 2008.
    100. ^ ICTV Master Species List 2008
      • This Excel file contains the official ICTV Master Species list for 2008. This spreadsheet lists all approved virus taxa and supersedes the previous taxonomy published as a part of the ICTV VIIIth Report. Produced by the International Committee on Taxonomy of Viruses. Retrieved on September 15, 2008
    101. ^ Baltimore D (1974). "The strategy of RNA viruses". Harvey Lect. 70 Series: 57–74. PMID 4377923. 
    102. ^ van Regenmortel MH, Mahy BW (2004). "Emerging issues in virus taxonomy". Emerging Infect. Dis. 10 (1): 8–13. PMID 15078590. 
    103. ^ Mayo MA (1999). "Developments in plant virus taxonomy since the publication of the 6th ICTV Report. International Committee on Taxonomy of Viruses". Arch. Virol. 144 (8): 1659–66. doi:10.1007/s007050050620. PMID 10486120. 
    104. ^ de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H (2004). "Classification of papillomaviruses". Virology 324 (1): 17–27. doi:10.1016/j.virol.2004.03.033. PMID 15183049. 
    105. ^ Mainly Chapter 33 (Disease summaries), pages 367–392 in:Fisher, Bruce; Harvey, Richard P.; Champe, Pamela C. (2007). Lippincott's Illustrated Reviews: Microbiology (Lippincott's Illustrated Reviews Series). Hagerstwon, MD: Lippincott Williams & Wilkins. pp. pages 367–392. ISBN 0-7817-8215-5. |alt=A photograph of the upper body of a man labelled with the names of viruses that infect the different parts
    106. ^ For common cold: National Institute of Allergy and Infectious Diseases (NIAID) > Common Cold. Last Updated December 10, 2007. Retrieved on 4 April, 2009
    107. ^ Chen C, Chiu Y, Wei F, Koong F, Liu H, Shaw C, Hwu H, Hsiao K (1999). "High seroprevalence of Borna virus infection in schizophrenic patients, family members and mental health workers in Taiwan". Mol Psychiatry 4 (1): 33–8. doi:10.1038/sj.mp.4000484. PMID 10089006. 
    108. ^ Margolis TP, Elfman FL, Leib D, et al. (October 2007). "Spontaneous reactivation of herpes simplex virus type 1 in latently infected murine sensory ganglia". J. Virol. 81 (20): 11069–74. doi:10.1128/JVI.00243-07. PMID 17686862. PMC 2045564. http://jvi.asm.org/cgi/pmidlookup?view=long&pmid=17686862. Retrieved 13 September 2008. 
    109. ^ Whitley RJ, Roizman B (May 2001). "Herpes simplex virus infections". Lancet 357 (9267): 1513–8. doi:10.1016/S0140-6736(00)04638-9. PMID 11377626. 
    110. ^ Barton ES, White DW, Cathelyn JS, et al. (May 2007). "Herpesvirus latency confers symbiotic protection from bacterial infection". Nature 447 (7142): 326–9. doi:10.1038/nature05762. PMID 17507983. 
    111. ^ Bertoletti A, Gehring A (2007). "Immune response and tolerance during chronic hepatitis B virus infection". Hepatol. Res. 37 Suppl 3: S331–8. doi:10.1111/j.1872-034X.2007.00221.x. PMID 17931183. 
    112. ^ Rodrigues C, Deshmukh M, Jacob T, Nukala R, Menon S, Mehta A (2001). "Significance of HBV DNA by PCR over serological markers of HBV in acute and chronic patients". Indian journal of medical microbiology 19 (3): 141–4. PMID 17664817. 
    113. ^ Nguyen VT, McLaws ML, Dore GJ (2007). "Highly endemic hepatitis B infection in rural Vietnam". Journal of Gastroenterology and Hepatology 22 (12): 2093–100. doi:10.1111/j.1440-1746.2007.05010.x. PMID 17645465. 
    114. ^ Witzany G (2006) "Natural Genome-Editing Competences of Viruses'" Acta Biotheor 54: 235–253.
    115. ^ Fowler MG, Lampe MA, Jamieson DJ, Kourtis AP, Rogers MF (2007). "Reducing the risk of mother-to-child human immunodeficiency virus transmission: past successes, current progress and challenges, and future directions". Am. J. Obstet. Gynecol. 197 (3 Suppl): S3–9. doi:10.1016/j.ajog.2007.06.048. PMID 17825648. 
    116. ^ Sauerbrei A, Wutzler P (2000). "The congenital varicella syndrome". Journal of perinatology : official journal of the California Perinatal Association 20 (8 Pt 1): 548–54. PMID 11190597. 
    117. ^ Garnett GP (February 2005). "Role of herd immunity in determining the effect of vaccines against sexually transmitted disease". J. Infect. Dis. 191 Suppl 1: S97–106. doi:10.1086/425271. PMID 15627236. http://www.journals.uchicago.edu/cgi-bin/resolve?JID31548. Retrieved 13 September 2008. 
    118. ^ Platonov AE (2006). "(The influence of weather conditions on the epidemiology of vector-borne diseases by the example of West Nile fever in Russia)" (in Russian). Vestn. Akad. Med. Nauk SSSR (2): 25–9. PMID 16544901. 
    119. ^ Shors p. 198
    120. ^ Shors pp. 199, 209
    121. ^ Shors p. 19
    122. ^ Shors p. 126
    123. ^ Shors pp. 193–194
    124. ^ Shors pp. 193–94
    125. ^ Shors p. 194
    126. ^ Shors pp. 192–193
    127. ^
    128. ^ Collier pp. 409–415
    129. ^ Patterson KD, Pyle GF (Spring 1991). "The geography and mortality of the 1918 influenza pandemic". Bull Hist Med. 65 (1): 4–21. PMID 2021692. 
    130. ^ Johnson NP, Mueller J (2002). "Updating the accounts: global mortality of the 1918–1920 "Spanish" influenza pandemic". Bull Hist Med 76 (1): 105–15. doi:10.1353/bhm.2002.0022. PMID 11875246. http://muse.jhu.edu/cgi-bin/resolve_openurl.cgi?issn=0007-5140&volume=76&issue=1&spage=105&aulast=Johnson. Retrieved 13 September 2008. 
    131. ^ Gao F, Bailes E, Robertson DL, et al. (1999). "Origin of HIV-1 in the Chimpanzee Pan troglodytes troglodytes". Nature 397 (6718): 436–441. doi:10.1038/17130. PMID doi:[http://dx.doi.org/10.1038%2F17130 10.1038/17130 9989410 doi:10.1038/17130]. 
    132. ^ Shors p. 447
    133. ^ Mawar N, Saha S, Pandit A, Mahajan U (December 2005). "The third phase of HIV pandemic: social consequences of HIV/AIDS stigma & discrimination & future needs" (PDF). Indian J. Med. Res. 122 (6): 471–84. PMID 16517997. http://www.icmr.nic.in/ijmr/2005/december/1201.pdf. Retrieved 13 September 2008. 
    134. ^ "Status of the global HIV epidemic" (PDF). UNAIDS. 2008. http://data.unaids.org/pub/GlobalReport/2008/jc1510_2008_global_report_pp29_62_en.pdf. Retrieved 15 September 2008. 
    135. ^ Towner JS, Khristova ML, Sealy TK, et al. (July 2006). "Marburgvirus genomics and association with a large hemorrhagic fever outbreak in Angola". J. Virol. 80 (13): 6497–516. doi:10.1128/JVI.00069-06. PMID 16775337. PMC 1488971. http://jvi.asm.org/cgi/pmidlookup?view=long&pmid=16775337. Retrieved 13 September 2008. 
    136. ^ Einstein MH, Schiller JT, Viscidi RP, Strickler HD, Coursaget P, Tan T, Halsey N, Jenkins D (June 2009). "Clinician's guide to human papillomavirus immunology: knowns and unknowns". The Lancet Infectious Diseases 9 (6): 347–56. doi:10.1016/S1473-3099(09)70108-2. PMID 19467474. 
    137. ^ Shuda M, Feng H, Kwun HJ, Rosen ST, Gjoerup O, Moore PS, Chang Y (October 2008). "T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus". Proceedings of the National Academy of Sciences of the United States of America 105 (42): 16272–7. doi:10.1073/pnas.0806526105. PMID 18812503. 
    138. ^ Pulitzer MP, Amin BD, Busam KJ (May 2009). "Merkel cell carcinoma: review". Advances in Anatomic Pathology 16 (3): 135–44. doi:10.1097/PAP.0b013e3181a12f5a. PMID 19395876. 
    139. ^ Koike K (2007). "Hepatitis C virus contributes to hepatocarcinogenesis by modulating metabolic and intracellular signalling pathways". J. Gastroenterol. Hepatol. 22 Suppl 1: S108–11. doi:10.1111/j.1440-1746.2006.04669.x. PMID 17567457. 
    140. ^ Hu J, Ludgate L (2007). "HIV-HBV and HIV-HCV coinfection and liver cancer development". Cancer Treat. Res. 133: 241–52. doi:10.1007/978-0-387-46816-7_9. PMID 17672044. 
    141. ^ Bellon M, Nicot C (2007). "Telomerase: a crucial player in HTLV-I-induced human T-cell leukemia". Cancer genomics & proteomics 4 (1): 21–5. PMID 17726237. 
    142. ^ Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S (2007). "Human papillomavirus and cervical cancer". Lancet 370 (9590): 890–907. doi:10.1016/S0140-6736(07)61416-0. PMID 17826171. 
    143. ^ Klein E, Kis LL, Klein G (2007). "Epstein-Barr virus infection in humans: from harmless to life endangering virus-lymphocyte interactions". Oncogene 26 (9): 1297–305. doi:10.1038/sj.onc.1210240. PMID 17322915. 
    144. ^ zur Hausen H (July 2008). "Novel human polyomaviruses—re-emergence of a well known virus family as possible human carcinogens". International Journal of Cancer. Journal International Du Cancer 123 (2): 247–50. doi:10.1002/ijc.23620. PMID 18449881. 
    145. ^ Alberts, Bruce; Alexander Johnson, Julian Lewis, Martin Raff, Keith Roberts, and Peter Walters (2002). Molecular Biology of the Cell; Fourth Edition. New York and London: Garland Science. ISBN 0-8153-3218-1. http://www.ncbi.nlm.nih.gov/books/bv.fcgi?call=bv.View..ShowTOC&rid=mboc4.TOC&depth=2. Retrieved 15 September 2008. 
    146. ^ Ding SW, Voinnet O (August 2007). "Antiviral immunity directed by small RNAs". Cell 130 (3): 413–26. doi:10.1016/j.cell.2007.07.039. PMID 17693253. http://linkinghub.elsevier.com/retrieve/pii/S0092-8674(07)00977-4. Retrieved 13 September 2008. 
    147. ^ Patton JT, Vasquez-Del Carpio R, Spencer E (2004). "Replication and transcription of the rotavirus genome". Curr. Pharm. Des. 10 (30): 3769–77. doi:10.2174/1381612043382620. PMID 15579070. 
    148. ^ Jayaram H, Estes MK, Prasad BV (2004). "Emerging themes in rotavirus cell entry, genome organization, transcription and replication". Virus Res. 101 (1): 67–81. doi:10.1016/j.virusres.2003.12.007. PMID 15010218. 
    149. ^ Greer S, Alexander GJ (December 1995). "Viral serology and detection". Baillieres Clin. Gastroenterol. 9 (4): 689–721. doi:10.1016/0950-3528(95)90057-8. PMID 8903801. 
    150. ^ Matter L, Kogelschatz K, Germann D (April 1997). "Serum levels of rubella virus antibodies indicating immunity: response to vaccination of subjects with low or undetectable antibody concentrations". J. Infect. Dis. 175 (4): 749–55. doi:10.1086/513967. PMID 9086126. 
    151. ^ Cascalho M, Platt JL (2007). "Novel functions of B cells". Crit. Rev. Immunol. 27 (2): 141–51. PMID 17725500. http://www.begellhouse.com/journals/2ff21abf44b19838,04b273632c9e9613,3c091a847067eeb2.html. Retrieved 14 September 2008. 
    152. ^ Le Page C, Génin P, Baines MG, Hiscott J (2000). "Interferon activation and innate immunity". Rev Immunogenet 2 (3): 374–86. PMID 11256746. 
    153. ^ Hilleman MR (October 2004). "Strategies and mechanisms for host and pathogen survival in acute and persistent viral infections". Proc. Natl. Acad. Sci. U.S.A. 101 Suppl 2: 14560–6. doi:10.1073/pnas.0404758101. PMID 15297608. PMC 521982. http://www.pnas.org/cgi/pmidlookup?view=long&pmid=15297608. Retrieved 14 September 2008. 
    154. ^ Asaria P, MacMahon E (2006). "Measles in the United Kingdom: can we eradicate it by 2010?". BMJ 333 (7574): 890–5. doi:10.1136/bmj.38989.445845.7C. PMID 17068034. 
    155. ^ Lane JM (2006). "Mass vaccination and surveillance/containment in the eradication of smallpox". Curr. Top. Microbiol. Immunol. 304: 17–29. doi:10.1007/3-540-36583-4_2. PMID 16989262. 
    156. ^ Arvin AM, Greenberg HB (2006). "New viral vaccines". Virology 344 (1): 240–9. doi:10.1016/j.virol.2005.09.057. PMID 16364754. 
    157. ^ Pastoret PP, Schudel AA, Lombard M (2007). "Conclusions—future trends in veterinary vaccinology". Rev. – Off. Int. Epizoot. 26 (2): 489–94, 495–501, 503–9. PMID 17892169. 
    158. ^ Palese P (2006). "Making better influenza virus vaccines?". Emerging Infect. Dis. 12 (1): 61–5. PMID 16494719. 
    159. ^ Thomssen R (1975). "Live attenuated versus killed virus vaccines". Monographs in allergy 9: 155–76. PMID 1090805. 
    160. ^ McLean AA (1986). "Development of vaccines against hepatitis A and hepatitis B". Rev. Infect. Dis. 8 (4): 591–8. PMID 3018891. 
    161. ^ Casswall TH, Fischler B (2005). "Vaccination of the immunocompromised child". Expert review of vaccines 4 (5): 725–38. doi:10.1586/14760584.4.5.725. PMID 16221073. 
    162. ^ Barnett ED, Wilder-Smith A, Wilson ME (July 2008). "Yellow fever vaccines and international travelers". Expert Rev Vaccines 7 (5): 579–87. doi:10.1586/14760584.7.5.579. PMID 18564013. http://www.future-drugs.com/doi/abs/10.1586/14760584.7.5.579?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dncbi.nlm.nih.gov. Retrieved 16 September 2008. 
    163. ^ Magden J, Kääriäinen L, Ahola T (2005). "Inhibitors of virus replication: recent developments and prospects". Appl. Microbiol. Biotechnol. 66 (6): 612–21. doi:10.1007/s00253-004-1783-3. PMID 15592828. 
    164. ^ Mindel A, Sutherland S (1983). "Genital herpes — the disease and its treatment including intravenous acyclovir". J. Antimicrob. Chemother. 12 Suppl B: 51–9. PMID 6355051. 
    165. ^ Witthöft T, Möller B, Wiedmann KH, et al. (November 2007). "Safety, tolerability and efficacy of peginterferon alpha-2a and ribavirin in chronic hepatitis C in clinical practice: The German Open Safety Trial". J. Viral Hepat. 14 (11): 788–96. doi:10.1111/j.1365-2893.2007.00871.x. PMID 17927615. 
    166. ^ Rudin D, Shah SM, Kiss A, Wetz RV, Sottile VM (November 2007). "Interferon and lamivudine vs. interferon for hepatitis B e antigen-positive hepatitis B treatment: meta-analysis of randomized controlled trials". Liver Int. 27 (9): 1185–93. doi:10.1111/j.1478-3231.2007.01580.x (inactive 13 July 2009). PMID 17919229. 
    167. ^ Dimmock p. 3
    168. ^ Bernard La Scola, Christelle Desnues, Isabelle Pagnier, Catherine Robert, Lina Barrassi, Ghislain Fournous, Michèle Merchat, Marie Suzan-Monti, Patrick Forterre, Eugene Koonin and Didier Raoult (2008). "The virophage as a unique parasite of the giant mimivirus". Nature 454 (7205): 100. doi:10.1038/nature07218. 
    169. ^ Goris N, Vandenbussche F, De Clercq K (April 2008). "Potential of antiviral therapy and prophylaxis for controlling RNA viral infections of livestock". Antiviral Res. 78 (1): 170–8. doi:10.1016/j.antiviral.2007.10.003. PMID 18035428. http://linkinghub.elsevier.com/retrieve/pii/S0166-3542(07)00435-4. Retrieved 16 September 2008. 
    170. ^ Carmichael L (2005). "An annotated historical account of canine parvovirus". J. Vet. Med. B Infect. Dis. Vet. Public Health 52 (7–8): 303–11. doi:10.1111/j.1439-0450.2005.00868.x. PMID 16316389. 
    171. ^ Chen YP, Zhao Y, Hammond J, Hsu H, Evans JD, Feldlaufer MF (October–November 2004). "Multiple virus infections in the honey bee and genome divergence of honey bee viruses". Journal of Invertebrate Pathology 87 (2–3): 84–93. doi:10.1016/j.jip.2004.07.005. PMID 15579317. 
    172. ^ Shors p. 584
    173. ^ Shors pp. 562–587
    174. ^ Dinesh-Kumar SP, Wai-Hong Tham, Baker BJ (2000). "Structure—function analysis of the tobacco mosaic virus resistance gene N". PNAS 97, 14789-94 PMID 11121079
    175. ^ Shors pp. 573–576
    176. ^ Soosaar JL, Burch-Smith TM, Dinesh-Kumar SP (2005). "Mechanisms of plant resistance to viruses". Nat. Rev. Microbiol. 3, pp. 789–98 PMID 16132037
    177. ^ Wommack KE, Colwell RR (March 2000). "Virioplankton: viruses in aquatic ecosystems". Microbiol. Mol. Biol. Rev. 64 (1): 69–114. doi:10.1128/MMBR.64.1.69-114.2000. PMID 10704475. PMC 98987. http://mmbr.asm.org/cgi/pmidlookup?view=long&pmid=10704475. 
    178. ^ Bergh O, Børsheim KY, Bratbak G, Heldal M (August 1989). "High abundance of viruses found in aquatic environments". Nature 340 (6233): 467–8. doi:10.1038/340467a0. PMID 2755508. 
    179. ^ Shors pp. 595–97
    180. ^ Bickle TA, Krüger DH (01 June 1993). "Biology of DNA restriction". Microbiol. Rev. 57 (2): 434–50. PMID 8336674. PMC 372918. http://mmbr.asm.org/cgi/pmidlookup?view=long&pmid=8336674. 
    181. ^ Barrangou R, Fremaux C, Deveau H, et al. (March 2007). "CRISPR provides acquired resistance against viruses in prokaryotes". Science (journal) 315 (5819): 1709–12. doi:10.1126/science.1138140. PMID 17379808. 
    182. ^ Brouns SJ, Jore MM, Lundgren M, et al. (August 2008). "Small CRISPR RNAs guide antiviral defense in prokaryotes". Science (journal) 321 (5891): 960–4. doi:10.1126/science.1159689. PMID 18703739. 
    183. ^ Prangishvili D, Garrett RA (2004). "Exceptionally diverse morphotypes and genomes of crenarchaeal hyperthermophilic viruses". Biochem. Soc. Trans. 32 (Pt 2): 204–8. doi:10.1042/BST0320204. PMID 15046572. http://www.biochemsoctrans.org/bst/032/0204/bst0320204.htm. 
    184. ^ Mojica FJ, Díez-Villaseñor C, García-Martínez J, Soria E (2005). "Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements". J. Mol. Evol. 60 (2): 174–82. doi:10.1007/s00239-004-0046-3. PMID 15791728. 
    185. ^ Makarova KS, Grishin NV, Shabalina SA, Wolf YI, Koonin EV (2006). "A putative RNA-interference-based immune system in prokaryotes: computational analysis of the predicted enzymatic machinery, functional analogies with eukaryotic RNAi, and hypothetical mechanisms of action". Biol. Direct 1: 7. doi:10.1186/1745-6150-1-7. PMID 16545108. http://www.biology-direct.com/content/1/1/7. 
    186. ^ Collier p.8
    187. ^ Lodish, Harvey; Berk, Arnold; Zipursky, S. Lawrence; Matsudaira, Paul; Baltimore, David; Darnell, James.Viruses:Structure, Function, and Uses Retrieved on September 16, 2008
    188. ^ Matsuzaki S, Rashel M, Uchiyama J, et al. (2005). "Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases". J. Infect. Chemother. 11 (5): 211–9. doi:10.1007/s10156-005-0408-9. PMID 16258815. 
    189. ^ Fischlechner, M; Donath, E (2007). "Viruses as Building Blocks for Materials and Devices". Angewandte Chemie International Edition 46 (18): 3184–93. doi:10.1002/anie.200603445. PMID 17348058. 
    190. ^ Soto CM, Blum AS, Vora GJ, et al. (April 2006). "Fluorescent signal amplification of carbocyanine dyes using engineered viral nanoparticles". J. Am. Chem. Soc. 128 (15): 5184–9. doi:10.1021/ja058574x. PMID 16608355. 
    191. ^ Blum AS, Soto CM, Wilson CD, et al. (2005). "An Engineered Virus as a Scaffold for Three-Dimensional Self-Assembly on the Nanoscale". Small, 7, 702.
    192. ^ Shors p. 331
    193. ^ a b c Artenstein AW, Grabenstein JD (October 2008). "Smallpox vaccines for biodefense: need and feasibility". Expert Review of Vaccines 7 (8): 1225–37. doi:10.1586/14760584.7.8.1225. PMID 18844596. http://www.future-drugs.com/doi/abs/10.1586/14760584.7.8.1225?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dncbi.nlm.nih.gov. Retrieved 12 July 2009. 
    194. ^ Aragón TJ, Ulrich S, Fernyak S, Rutherford GW (2003). "Risks of serious complications and death from smallpox vaccination: a systematic review of the United States experience, 1963–1968". BMC public health 3: 26. doi:10.1186/1471-2458-3-26. PMID 12911836. 
    195. ^ Weiss MM, Weiss PD, Mathisen G, Guze P (2004). "Rethinking smallpox". Clin. Infect. Dis. 39 (11): 1668–73. doi:10.1086/425745. PMID 15578369. 

    Bibliography

    • Collier, Leslie; Balows, Albert; Sussman, Max (1998) Topley and Wilson's Microbiology and Microbial Infections ninth edition, Volume 1, Virology, volume editors: Mahy, Brian and Collier, Leslie. Arnold. ISBN 0340663162.
    • Dimmock, N.J; Easton, Andrew J; Leppard, Keith (2007) Introduction to Modern Virology sixth edition, Blackwell Publishing, ISBN 1405136456.
    • Knipe, David M; Howley, Peter M; Griffin, Diane E; Lamb, Robert A; Martin, Malcolm A; Roizman, Bernard; Straus Stephen E. (2007) Fields Virology, Lippincott Williams & Wilkins. ISBN 0781760607.
    • Shors, Teri (2008). Understanding Viruses. Jones and Bartlett Publishers. ISBN 0763729329.

    External links

    • ViralZone A Swiss Institute of Bioinformatics resource for all viral families, providing general molecular and epidemiological information

    Find more about Virus on Wikipedia's sister projects:

    Search Wiktionary Definitions from Wiktionary
    Search Wikibooks Textbooks from Wikibooks
    Search Wikiquote Quotations from Wikiquote
    Search Wikisource Source texts from Wikisource
    Search Commons Images and media from Commons
    Search Wikinews News stories from Wikinews
    Search Wikiversity Learning resources from Wikiversity